WO2007032224A1 - Cultured cell sheet and method for preparation thereof - Google Patents
Cultured cell sheet and method for preparation thereof Download PDFInfo
- Publication number
- WO2007032224A1 WO2007032224A1 PCT/JP2006/317512 JP2006317512W WO2007032224A1 WO 2007032224 A1 WO2007032224 A1 WO 2007032224A1 JP 2006317512 W JP2006317512 W JP 2006317512W WO 2007032224 A1 WO2007032224 A1 WO 2007032224A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- cell
- thin film
- ipe
- collagen gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
Definitions
- the present invention relates to a cultured cell sheet and a method for producing the same. Specifically, the present invention relates to a cultured cell sheet having a cell layer derived from iris pigment epithelial cells or retinal pigment epithelial cells and a method for producing the same.
- the cultured cell sheet provided by the present invention is used in the treatment of retinal diseases that require reconstruction of the retinal pigment epithelium, such as age-related macular degeneration, retinal pigment degeneration, diabetic retinopathy, myopic retina choroidal atrophy, and retinal pigment tumor. It can be used as a transplant material.
- retinal diseases that require reconstruction of the retinal pigment epithelium, such as age-related macular degeneration, retinal pigment degeneration, diabetic retinopathy, myopic retina choroidal atrophy, and retinal pigment tumor. It can be used as a transplant material.
- fibroblast growth factor bFGF
- bFGF fibroblast growth factor
- regenerative medicine has been introduced in the field of ophthalmology. For example, attempts have been made to treat corneal epithelial diseases using corneal epithelial stem cells and amniotic membrane (Non-patent Document 1). With the advancement of regenerative medicine, aggressive treatment has been tried for diseases that have not been treated before. On the other hand, for intractable retinal diseases, there are still no established treatments, and many of the conditions are unknown. There are many retinal diseases that become severe once they develop. Although it is not at the stage where clinical results can be evaluated, regenerative medicine using cell transplantation has been developed for retinal chromatic degeneration and age related macular degeneration (AMD), which are representative of intractable retinal diseases. Application is being attempted.
- AMD age related macular degeneration
- AMD age-related macular degeneration
- wet AMD which is said to be common among Japanese, causes severe visual impairment due to the formation of the choroidal neovascular plate in the macular region.
- vitreous hemorrhage causes sudden visual impairment.
- Traditionally it was said to be more common among whites, but it often occurs after middle age, and the number of Japanese people is increasing as the population ages.
- the subretinal neovascularization that causes it is removed together with the vitreous, surgical treatment to move the macular retina, and special compounds and laser light are used. Attempts have been made to eliminate new blood vessels.
- Non-Patent Document 2 uses IPE as a surrogate cell for retinal pigment epithelium that has been impaired after CNV removal, but its effect is far from clinical application. .
- RPE retinal pigment epithelium
- AMD age-related macular degeneration
- the iris itself is derived from the mesoderm and neuroectoderm, but IPE is derived from the neuroectoderm and is embryologically identical in origin to RPE.
- IPE which is clinically easy to collect, has also been transplanted into the RPE deficient part as a substitute for the dropped RPE.
- the cultured IPE shows almost no pigment and it is difficult to confirm the transplanted cells directly. Therefore, when transplanting cultured cells, it is difficult to discuss the relationship between postoperative visual function and transplanted cells.
- Non-Patent Document 1 Takahiro Nakamura, Shigeru Kinoshita: Position of amniotic membrane in eye regenerative medicine, ophthalmic surgery
- Non-Patent Document 2 Abe T. et al., Tohoku J Exp Med 191: 7-20,2000
- Non-Patent Document 3 Peyman GA. Et al., Ophthalmic Surg 22: 102-108, 1991
- Non-Patent Document 4 Algvere PV. Et al., Graefes Arch Clin Exp Ophthalmol 235: 149-158,
- Non-Patent Document 5 Weisz JM. Et al, Retina 19: 540-545, 1999
- Non-Patent Document 6 Abe T. et al., Tohoku J Exp Med 189: 295-305, 1999
- Non-Patent Document 7 Thumann G. et al., Arch Ophthalmol 118: 1350-1355, 2000
- Non-Patent Document 8 Del Priore LV. Et al "Am J Ophthalmol 131: 472-480, 2001
- RPE retinal pigment epithelium
- an object of the present invention is to provide a transplant material that can be used as an alternative to RPE and that exhibits a high therapeutic effect (good reconstruction of RPE) and a method for producing the same.
- IPE cells iris pigment epithelial cells
- RPE cells retinal pigment epithelial cells
- the substrate for constructing a cell sheet that can be expected to have a high therapeutic effect has the following characteristics: (1) (2) High strength, (3) Good adhesion between cells to be used, and good adhesion between cells to be used and substrate, and (4) Cells seeded on them We thought that it would be required to be able to maintain the functions of Looking at these characteristics and searching for a substrate, we found that a vitrified thin-film collagen gel (collagen gel thin film) was optimal.
- the collagen gel thin film has a feature that there is almost no swelling at the time of transition from a dry state to a wet state, as compared to a product made from a commonly distributed collagen such as natural collagen or collagen.
- a cultured cell sheet comprising a vitrified collagen gel thin film having a thickness of about 20 zm or less, and an iris pigment epithelial cell or retinal pigment epithelial cell-derived cell layer formed thereon.
- the collagen gel thin film has a support for maintaining its shape.
- the cultured cell sheet according to any one of [1] to [3].
- the cell layer has a single layer structure
- the cell density of the cell layer is about 1000-10000 cells / mm 2 ;
- the planar view shape of the cells constituting the cell layer is a polygonal shape
- the cell layer has phagocytic ability
- a method for producing a cultured cell sheet comprising the following steps:
- vitrified collagen gel thin film having a thickness of about 20 / m or less
- Substrate consisting of a vitrified collagen gel thin film with a thickness of about 10 ⁇ m or less
- FIG. 1 Schematic representation of the support used to produce a vitrified collagen gel film
- FIG. 2 is a stereomicrograph of an IPE cell sheet constructed on a collagen gel thin film.
- FIG. 3 is a stereomicrograph of an RPE cell sheet constructed on a collagen gel thin film.
- FIG. 4 is a diagram showing the results (stereomicrograph) of an experiment in which beads were phagocytosed on an IPE cell sheet constructed on a collagen gel thin film.
- FIG. 5 is a diagram showing the results of an experiment in which beads were phagocytosed on an RPE cell sheet constructed on a collagen gel thin film (photomicrograph).
- cultured cell sheet refers to a sheet-like construct comprising a cell layer formed by culturing predetermined cells collected from a living body in vitro.
- cultured IPE sheet refers to a sheet-like construct comprising a cell layer formed by culturing iris pigmented epithelial cells (IPE cells) collected from a living body in vitro
- cultured RPE sheet refers to a sheet-like construct comprising a cell layer formed by culturing retinal pigment epithelial cells (RPE cells) collected from a living body in vitro.
- iris pigment epithelial cells IPE cells
- iris pigment epithelial stem cells ie, includes iris pigment epithelial stem cells.
- retinal pigment epithelial cell RPE cell
- irid pigment epithelial cell-derived cell layer refers to a cell layer constructed by culturing iris pigment epithelial cells.
- cell layer derived from retinal pigment epithelial cells refers to a cell layer constructed by culturing retinal pigment epithelial cells.
- collagen gel refers to collagen having a network structure containing a large amount of water, and is prepared by gelling a collagen sol.
- collagen gel dry body means that collagen gel is thinned under vitrified conditions. The substance obtained by drying into a shape is added.
- collagen gel thin film refers to a sheet-like structure obtained by rehydrating a dried collagen gel.
- vitrification refers to changing to a hard and transparent substance by drying (Takush i E., Edible eyeballs from fish. Nature 345, 298, 1990).
- the first aspect of the present invention relates to a cultured cell sheet.
- the cultured cell sheet of the present invention comprises (1) a vitrified collagen gel thin film having a thickness of about 20 ⁇ m or less, and (2) iris pigmented epithelial cells (IPE cells) or Cell layer derived from retinal pigment epithelial cells (RPE cells).
- IPE cells iris pigmented epithelial cells
- RPE cells retinal pigment epithelial cells
- the cell layer formed on the collagen gel thin film is constructed of cells derived from IPE or RPE. This is confirmed by examining the morphology of cells contained in the cell layer and the presence or absence of expression of markers characteristic of IPE cells (or RPE cells) (eg cytokeratin, RPE65, CRALBP, pP344, Bestro phin). be able to.
- markers characteristic of IPE cells eg cytokeratin, RPE65, CRALBP, pP344, Bestro phin.
- the cell layer preferably has some of the following characteristics, particularly preferably all the following characteristics.
- the cell layer has a single layer structure (single layer structure). This is one of the features that biological IPE and RPE have in common.
- a cell density of RPE biological is about 3000 to about 5000 cells ZMM 2.
- the cell density in the cell layer of the present invention is preferably about 1000 to about 100,000 cells Zmm 2 , more preferably about 2000 to about 8000 cells / mm 2 .
- the planar view shape of the cells constituting the cell layer is a polygonal shape. This is one of the features of RPE cells in the body. By observing this feature, the cell layer of the present invention is expected to exhibit a function similar to that of RPE, similar to the retinal pigment epithelium of a living body.
- the cell layer of the present invention is expected to exhibit the same function as RPE in a living body.
- Tight junctions are observed between cells in the cell layer. The presence or absence of tight junctions can be confirmed by examining the expression of tight junction-related protein ZO-1.
- the cell layer has phagocytic ability. Living RPE cells exert an important function of metabolism of photoreceptors by their phagocytic ability. As the cell layer has phagocytic ability, it is expected to exhibit the same functions as RPE.
- IPE cells iris pigment epithelial cells
- RPE cells retinal pigment epithelial cells
- the collagen gel thin film can be prepared according to the method described in International Publication No. 014774 (WO2005 / 014774A1) or Cell transplantation, Vol. 13, ⁇ .463-473, 2004.
- the outline of the preparation method is shown below (for details, see the above publication and literature).
- a collagen aqueous solution for example, type I collagen aqueous solution
- a predetermined concentration for example, 0.5% (w / v)
- buffer solution for example, phosphate buffer
- the container is transferred to a clean bench under conditions of 10 ° C and 40% humidity, and left for 2 days with the container open to dry completely.
- the collagen gel is vitrified.
- the dried collagen gel thus obtained is left as it is or after rinsing with PBS or the like and subsequent drying (for example, drying under the same conditions as the above drying treatment), and then aseptic at room temperature.
- PBS or the like and subsequent drying (for example, drying under the same conditions as the above drying treatment), and then aseptic at room temperature.
- a collagen gel thin film can be obtained by returning the dried collagen gel to a wet state (rehydration) with an appropriate liquid (for example, a physiological saline, a buffer solution such as PBS, or a culture solution).
- a vitrified collagen gel thin film is used.
- a vitrified collagen gel thin film has excellent strength and high transparency. In addition, it can be made extremely thin during use (wet state) with very little swelling during the transition from the dry state to the wet state.
- a normal collagen sheet that has not been vitrified for example, a type I collagen sheet disclosed in JP-A-2005-229869
- Such a thick collagen sheet lacks qualification as a substrate for cultured cell sheets that are transplanted under the retina where physical space is scarce.
- the swelling at the time of transition from the dry state to the wet state is very small. Therefore, the extremely thin state can be obtained at the time of use when used as a substrate for a cultured cell sheet. This is the biggest advantage of the collagen gel thin film.
- both the IPE cells and the RPE cells adhere well to the vitrified collagen gel thin film, and the adhesion between cells is also improved. It was good. In addition, high cell growth efficiency can be obtained and seeded. It was found that the function of the cells retained was retained.
- the vitrified collagen gel thin film has many characteristics preferable as a substrate for constructing a cell layer derived from IPE cells or a cell layer derived from RPE cells.
- a cultured cell sheet (cultured IPE sheet or cultured RPE sheet) obtained using a vitrified collagen gel thin film retains strength suitable for transplantation, and can be expected to have a high therapeutic effect that is easy to handle. It will be a thing.
- the thickness of the collagen gel thin film used in the present invention is about 20 zm or less.
- the substrate as a carrier should be as thin as possible.
- the substrate is required to have sufficient strength to support the cell layer.
- the thickness of the collagen gel thin film as a substrate is preferably about 5 ⁇ m to 7j3 ⁇ 43 ⁇ 420 ⁇ m, more preferably about 5 ⁇ m to about 15 ⁇ m, and still more preferably about 5 ⁇ m to about 10 ⁇ m.
- the type and origin of collagen constituting the collagen gel thin film are not particularly limited.
- Collagen types include type I collagen, type III collagen, type IV collagen, type VIII collagen and the like.
- a collagen gel thin film is constructed in a state where multiple types of collagen are mixed.
- the collagen gel thin film is composed of type I collagen (or main component is type I collagen). This is because very good growth of IPE cells and RPE cells is observed on a collagen gel thin film made of type I collagen (see Examples below), and type I collagen is easy to supply stably.
- Examples of the origin of collagen include horse, ushi, pig, hidge, monkey, chimpanzee, and human. You can also use (recombinant) human collagen prepared by gene recombination technology. Of these, collagen from recombinant human collagen, horse, ushi, or pig is preferred. This is because it is easy to obtain.
- a physiologically active substance may be added to the collagen gel thin film.
- Physiologically active substances here include cell growth factor, differentiation-inducing factor, cell adhesion factor, site force in, angiogenesis Inhibitors, analgesic anti-inflammatory agents and the like can be exemplified. Different physiologically active substances may be added in combination.
- a collagen gel thin film having a compressive fracture strength of 3 ⁇ 4 times to 20 times (about 100 g to about 800 g when measured under the following measurement conditions) as compared to the state before vitrification (collagen gel).
- a collagen gel thin film that satisfies this condition can be obtained by keeping it for about 40 days or more when it is dried at room temperature. In order to homogenize the gelation of the collagen contained, it is desirable to control the gelling process at 15 ° C or 4 ° C.
- a collagen gel thin film having an absorbance at 400 nm of 10% to 70% (absorbance of about 0.1 to 0.2) as compared to the state before vitrification (collagen gel) is used.
- a collagen gel thin film satisfying this condition can be obtained by storing and maintaining after drying for about 40 days or more.
- the gelation process can be controlled at 15 ° C or 4 ° C.
- a method performed in this field such as reduced pressure drying or freeze drying can be used.
- a collagen gel thin film with a support it is preferable to prepare a collagen gel thin film with a support.
- the support By using the support, the morphology of the collagen gel thin film can be maintained. At the same time, peeling from the container during the production of the thin film becomes easy. As a result, it is possible to ensure and maintain the flatness of the collagen gel thin film at the time of cell seeding or during the following culture. Cell adhesion, proliferation, and organization are improved, and a high-quality cell layer is constructed.
- the collage gel thin film can be peeled off from the culture vessel relatively easily by grasping the support with tweezers. That is, by using the support, the operability when collecting the prepared cultured cell sheet is improved. Furthermore, since the cultured cell sheet can be collected while maintaining its shape by the support, it can be transferred to a transplantation device without damaging the formed cell layer. However, a highly flat cultured cell sheet suitable for transplantation can also be obtained.
- the collagen gel thin film with the support can be prepared, for example, by the following procedure.
- a nylon membrane molded into a donut shape is prepared as a support.
- collagen sol is prepared and added to the culture dish, gelled, and vitrified by the procedure described above. With the above steps, a collagen gel thin film having a support attached on one side of the outer peripheral portion is completed.
- the material of the support examples include synthetic fibers (synthetic resins) such as nylon, natural fibers such as cotton, bioabsorbable materials such as polylactic acid, and metals.
- synthetic fibers synthetic resins
- the shape of the support is preferably circular (circle, ellipse, square, etc.).
- the support is used before transplanting the cultured cell sheet to the patient (from the preparation of the cultured cell sheet to immediately before transplantation of the cultured cell sheet). Is removed.
- IPE cells can be collected routinely from the recipient himself or from the iris of a suitable donor. For example, first, a peripheral iris excision is performed under local anesthesia, and an iris piece is collected. Epithelial cells are separated from the collected iris pieces by trypsinization or manual methods. The separated epithelial cells (IPE cells) are cultured in an appropriate culture medium in which IPE cells can grow as necessary.
- an appropriate culture medium for example, a commercially available F12 medium supplemented with serum, antibiotics (amphotericin, gentamicin, penicillin, streptomycin, etc.) and the like can be used.
- antibiotics amphotericin, gentamicin, penicillin, streptomycin, etc.
- serum to be added to the medium human serum, fetal bovine serum, sheep serum and the like can be used.
- autologous serum ie, the recipient's own serum
- autologous serum that eliminates the risk of causing immune rejection.
- protein components derived from heterologous animals such as commercially available Epi Life TM (Cascade), MCDB153 medium (Nissui Pharmaceutical Co., Ltd.), and media prepared by modifying the amino acid composition of these mediums are completely removed.
- a serum-free medium containing no serum can also be used. That is, a serum-free culture method may be employed as the culture method in the present invention. In such an embodiment, problems such as rejection of immunity due to contamination of serum-derived components can be avoided.
- a culture container (culture dish) whose surface is coated with type I collagen, type IV collagen, fibronectin, laminin or the like. This is because adhesion of IPE cells to the surface of the culture container is promoted, and good growth is performed.
- a culture vessel coated with type I collagen, type IV collagen, or fibronectin see Examples below.
- the surface of a synthetic polymer or the like is treated with a nanotechnology technique and a material having an interface structure suitable for IPE cell growth is used.
- the temperature conditions for culturing IPE cells are not particularly limited as long as the IPE cells grow. For example, about 25 ° C to about 45 ° C, preferably about 30 ° C in consideration of the growth efficiency. To about 40 ° C, more preferably about 37 ° C.
- the culture time (that is, the time of primary culture) for subsequent subculture is, for example, 1 to 60 days, although it varies depending on the state of the cells used.
- the recipient's own IPE cells when available, it is preferable to use the recipient's own IPE cells. This is because it is possible to produce a cultured IPE sheet that does not cause immune rejection when transplanted, that is, transplantation without immune rejection becomes possible. If the recipient's own IPE cells are not available or difficult to obtain, non-recipient IPE cells can be used, but in this case the donor should be selected in consideration of immunocompatibility. preferable.
- Subculture cell suspension preparation
- Subculture can be performed after the IPE cells subjected to culture have proliferated.
- Subculture can be performed as follows. First, after removing the cell culture medium, the cells are washed with PBS ( ⁇ ) solution, treated with trypsin-EDTA or the like to peel the cells from the surface of the culture container, and the cells are collected in the next step. A culture solution is added to the collected cells to prepare a cell suspension.
- the cell suspension is seeded in a culture vessel in the same manner as in the primary culture described above and used for culture.
- Subculture can be performed under the same culture conditions as the above primary culture.
- the culture time varies depending on the state of the cells used and is, for example, 1 to 60 days.
- the above subculture can be performed multiple times as necessary. By repeating subculture, the number of cells can be increased and a cell suspension with a high cell density can be prepared. It is preferable to finally prepare a cell suspension having a cell density of about 20,000 cells / ml to 100,000 cells / ml.
- RPE cells can be collected in a conventional manner from the recipient itself or from the subretinal area of a suitable donor. For example, a scleral incision is first performed under local anesthesia, and the retinal pigment epithelium under the peripheral retina sufficiently separated from the macula is removed. Epithelial cells are separated from the collected retinal pigment epithelium by trypsin treatment or manual method. The separated epithelial cells (RPE cells) are cultured in an appropriate culture medium in which RPE cells can grow as necessary. As the culture medium, for example, a medium obtained by adding serum, antibiotics (amphotericin, gentamicin, penicillin, streptomycin, etc.) to a commercially available DMEM medium can be used.
- RPE cell passages and cell suspensions can be prepared using the same procedures and conditions as for IPE.
- Step (1) and step (2) described above are performed independently. Therefore, the power to say that any step can be performed first (or both at the same time). Considering the nature of the material (ie, collagen, cells) handled in each step, the preparation of the collagen gel thin film is usually preceded. And implement.
- Step of seeding and culturing cells the cells (IPE cells or RPE cells) prepared by the above procedure are seeded on the collagen gel thin film prepared by the above procedure.
- a culture solution is added to a dried collagen gel prepared in a culture vessel and incubated (for example, 37 ° C, about 5 to 20 minutes).
- the cell suspension is seeded on the vitrified collagen gel thin film thus obtained.
- it is preferable to adjust the number of cells to be seeded so that a cell layer having a desired cell density is formed in the finally prepared cultured cell sheet.
- the culture can be performed under the same conditions as the primary culture described above.
- the culture time varies depending on the state of the cells used, but is, for example, 1 day to 60 days.
- the cell culture here is preferably performed in the absence of heterologous animal cells.
- “in the absence of heterologous animal cells” means that animal cells that are heterologous to the cells are not used as conditions for culturing IPE cells or RPE cells.
- the conditions are such that cells of animal species other than humans, such as mice and rats, do not exist (coexist) in the culture medium.
- the primary culture (and subculture as necessary) is also preferably performed in the absence of heterologous animal cells.
- the collected IPE cells or RPE cells may be seeded directly on the collagen gel thin film and cultured. That is, the culture process (primary culture and subculture of IPE cells or RPE cells) performed before seeding on the collagen gel thin film may be omitted. In this way, the culturing operation can be simplified, and the cell layer can be constructed by a substantially one-step culturing operation.
- a cultured cell in which a cell layer composed of IPE-derived cells (when IPE cells are used) or RPE-derived cells (when RPE cells are used) is formed on a collagen gel thin film.
- a sheet is obtained.
- the cultured cell sheet can be collected by releasing the attachment.
- the collagen gel thin film is peeled off using tweezers or a knife.
- the collage gel thin film can be peeled off relatively easily in the culture container by grasping the support with tweezers.
- the support can maintain the shape of the collagen gel thin film and the cultured cell sheet at the time of peeling.
- the cultured cell sheet of the present invention is provided, for example, in a state of being stored in a glass or plastic container and immersed in a cell culture medium or a storage solution such as a UW solution.
- the cultured cell sheet prepared by the above method is a transplant material for the treatment of diseases that require RPE reconstruction, such as age-related macular degeneration, retinitis pigmentosa, diabetic retinopathy, myopic choroidal atrophy, and retinal pigment tumors. It can be used as an alternative to the pigment epithelium.
- ALD age-related macular degeneration
- CNV choroidal neovascularization
- 3 ports are prepared and the vitreous body is excised with a vitreous cutter, and is weak against the retina near the CNV that has been confirmed by a scanning laser ophthalmoscope (S LO) examination before surgery After solidification of diathermy, make a small hole and grasp CNV with an insulator to remove it. After excision of CNV, the subretinal space is washed with a cell transplant needle to form a shallow retinal detachment state. The cultured cell sheet is transplanted into the space thus formed.
- S LO scanning laser ophthalmoscope
- Thickness prepared according to the method described in WO 2005/014774 pamphlet A vitrified collagen gel thin film having a thickness of about 20 ⁇ m was obtained from Asahi Techno Glass Co., Ltd. (Chiba, Japan). The outline of the method for preparing the collagen gel thin film is described below.
- a circular support as shown in FIG. 1 was prepared by cutting a nylon membrane (Amersham # RPN1782B), sterilized, and placed in a hydrophobic polystyrene 24-wall plate.
- a cell culture solution 0.5% type 1 collagen aqueous solution (Ushi type I collagen, Nitta Gelatin Co., Ltd.) was placed in a sterile conical tube cooled on ice and mixed uniformly.
- the collagen mixture was placed in a 24-well plate containing the above support, and then gelled by maintaining it in a humidified incubator at 37 ° C in the presence of 5% CO / 95% air for 2 hours.
- This final concentration 0.25% collagen gel was vitrified by aseptically drying for 2 days in a clean bench under conditions of 10 ° C and 40% humidity with the lid removed. By adding 3 ml of PBS to this, the dried vitrified collagen gel was rehydrated. Rinse several times with 3 ml of PBS. Furthermore, this collagen gel thin film was aseptically dried for 2 days in a clean bench under conditions of 10 ° C and 40% humidity with the lid removed. Thereafter, it was kept aseptically stored at room temperature. In the following experiments, a dried collagen gel that had been stored for 40 days or longer was used.
- the collagen gel thin film obtained by returning the dried collagen gel to a wet state has very high transparency and strength (for details, see International Publication No. 2005Z014774 pamphlet). In addition, almost no swelling is observed when moving from a dry state to a wet state.
- a cultured IPE sheet using porcine IPE cells was prepared by the following procedure.
- the eyeballs were removed from the corpses.
- the eyeball was immersed in about 20 ml of intraocular perfusate containing penicillin and streptomycin within 10 hours, and the following treatment was performed within 1 hour.
- the outer part of the cornea was cut about 5 mm with scissors and separated into an anterior ocular tissue containing the cornea and a posterior ocular tissue containing the retina.
- An eye tissue force was removed using cesi.
- the iris pigmented tissue could be obtained by thoroughly washing with an intraocular perfusate except for the jelly-like substance contained therein. Subsequent processing is When there was no description, it carried out paying attention to aseptic operation in the clean bench.
- the iris pigmented epithelial cells are black, and the area of the iris tissue from which the cells have been detached becomes pale and skin-colored. Therefore, cell detachment was continued until the black area could not be visually confirmed from the iris tissue.
- the solution was aspirated with a pipette and poured into a 15 ml centrifuge tube, and 2 ml of the IPE culture solution was poured into the dish and again poured into a 15 ml centrifuge tube to wash the dish. After another washing operation, centrifugation was performed at 4 ° C and 3000 mm for 2 minutes.
- IPE medium was used for IPE cell culture. 2-4 To the tube containing the pellet obtained in 2 above, 4 ml of IPE medium was added to suspend the pellet, and the whole solution was added to a 6-well plate (IWAKI) coated with type I collagen. One extra IPE cell is added to one well. Cell culture is incubator with 5% CO and 37 ° C
- the medium was not changed after the culture, and the plate was left to stand. This is the period when IPE cells adhere to the plate, and the cells were observed daily. It takes about 7-10 days for the cells to adhere to the plate. Thereafter, the IPE medium was changed every 3 days.
- the medium is exchanged according to the following procedure. First, the IPE culture solution was removed using an lml pipette, and the PBS was removed by washing the lml cache plate, and then washed. When culturing IPE cells, black granules are seen in the medium. This granule is removed by the washing operation. The PBS washing operation is repeated until no granules are observed in the collected PBS.
- the washing operation is performed 5 times at the first medium change, The medium was changed twice. Thereafter, the IPE culture solution was returned to the lml cache incubator and the culture was continued. The cells became confluent after 2 weeks of culture, and the number of cells reached about 5-7 ⁇ 10 5 cells / well.
- the tube was transferred to a liquid nitrogen container and left for one week.
- the tube was transferred to a high-temperature bath preliminarily kept at 37 ° C and thawed immediately.
- the solution in the tube was transferred to a 15 ml tube, 4 ml of IPE medium was added, and centrifuged at 4 ° C and 3000 mm for 2 minutes. After removing the supernatant, add 1 ml of IPE culture solution, suspend, and inoculate the cells on a 24-well plate coated with type I collagen and incubate under conditions of 5% CO and 37 ° C. The culture was carried out. Observation was performed one week later, and cells adhering to the plate were observed.
- a pellet containing 5 X 10 4 IPE cells was prepared according to 2-4, and 2 ml of IPE culture solution was added and suspended to obtain a cell suspension.
- the IPE culture solution was placed in a 24-well plate prepared in step 1 to which a dry collagen gel with a thickness of 20 ⁇ m was attached, and incubated at 37 ° C for 15 minutes. The dried body was rehydrated. After adding 1 ml of the above cell suspension onto the wet collagen gel thin film (about 20 ⁇ m thick) obtained as a result, the plate was transferred to an incubator with 5% CO and 37 ° C, and cultured. did. After culturing, the IPE medium was changed every 3 days using the same method as in 2-3. About 2 to 3 days after the start of culture, the cells adhered to the collagen gel thin film and reached confluence about 2 weeks later (Fig. 2).
- a cultured RPE sheet using porcine RPE cells was prepared by the following procedure.
- the eyeballs were removed from the corpses.
- the eyeball was immersed in about 20 ml of intraocular perfusate containing penicillin and streptomycin within 10 hours, and the following treatment was performed within 1 hour.
- the outer part of the cornea was cut about 5 mm with scissors and separated into anterior ocular tissue containing the cornea and posterior ocular tissue containing the retina.
- Tissue strength was obtained by removing the vitreous body and retina using cesi, and then removing the scleral retinal pigment membrane and the choroid present on the sclera side. Retinal pigment tissue could be obtained by thorough washing with intraocular perfusate. Subsequent processing was performed with care in aseptic operation in a clean bench unless otherwise stated.
- the retinal pigment epithelial cells are black, and the area of the retina pigment tissue from which the cells have been detached becomes white. Therefore, cell detachment was continued until the black area from the retinal pigment tissue could not be visually confirmed.
- the solution was aspirated with a pipette and poured into a 15 ml centrifuge tube, and 2 ml of RPE culture solution was poured into the dish and again poured into a 15 ml centrifuge tube to wash the dish. After another washing operation, centrifugation was performed at 4 ° C and 3000 mm for 2 minutes.
- RPE medium was used for RPE cell culture unless otherwise stated. 3- In the tube containing the pellet obtained in 2 above, 4 ml of RPE medium was added to suspend the pellet, and the entire solution was added to a 6-well plate (IWAKI) coated with type I collagen. This means that one eye has RPE cells per eye. Cell culture was performed in an incubator with 5% CO and 37 ° C. The medium was not changed after the culture, and the plate was left to stand. This was the time when RPE cells adhered to the plate, and the cells were observed daily. It takes about 7-10 days for the cells to adhere to the plate. Thereafter, the RPE medium was changed every 3 days. The medium was exchanged by the same procedure as 2-3. Cells became confluent after 3 weeks of culture and the cell count reached approximately 3-5 x 10 5 cells / well.
- RPE cells were preserved in the same manner as 2-5. Cryopreservation One week after RPE culture Attempting to cultivate in lysis, cells observed to adhere to the plate one week after the start of culture. It was.
- a cultured RPE sheet was prepared in the same manner as in 2- 6. About 2 to 3 days after the start of sheet preparation, the cells adhered to the collagen sheet and reached confluence after about 3 weeks (Fig. 3).
- the phagocytic ability of the cultured IPE sheet was tested using latex beads.
- the cultured IPE sheet obtained in 2-6. was used.
- 1.0 ⁇ 10 9 uncoated latex beads (polyscience) having an average diameter of 1 ⁇ m were placed in an IPE culture solution in which an IPE sheet was immersed.
- the bead is 1.0 X 10 9 pieces / lml / 1 sheet.
- a 24-well plate containing a cultured IPE sheet was placed in a 37 ° C incubator and allowed to stand. After 6 hours, the latex bead-containing IPE medium was removed. After adding 1 ml of PBS and shaking the plate, washing was performed by removing PBS.
- This washing operation was performed until latex beads were no longer observed in the removed PBS, and was usually performed five times.
- free beads that have not been taken up into the cells are removed from the culture medium.
- PBS was removed, lml of 100% acetone was added to the well, and the mixture was allowed to stand for 15 minutes. By this operation, the cells are fixed. Acetone was removed, and the well was washed by adding 1 ml of PBS.
- the washing operation was performed twice. The culture IPE sheet was carefully peeled from the well using cesi, and the culture IPE sheet was placed on a slide glass so that the cell surface was up.
- the phagocytic ability of the cultured RPE sheet obtained in 3-6 was also evaluated using the same procedure. Granules were observed only in the cultured RPE sheet with beads added, confirming the phagocytic ability (Fig. 5).
- the pellet was obtained by centrifuging at 4 ° C and 6000 mm for 3 minutes and removing the supernatant. This pellet contains mainly the optic nerve outer segment.
- the pellet was suspended by adding 500 ⁇ l of pH 8.0 PBS containing 100 mM NaCl, and 1 mg of fluorescent dye SNAEFL succinimidino ester dissolved in 100 ⁇ l of anhydrous dimethylformamide was collected. Fluorescent labels were introduced by standing at room temperature in a dark place for 30 minutes.
- the culture IPE sheet was carefully peeled off from the tool using sushi, and the culture IPE sheet was placed on a slide glass so that the cell surface was up. 30 ⁇ L of mounting medium (Vector) was placed on the sheet, sealed with a cover glass, and then observed under a fluorescence microscope. Since fluorescence is observed when the optic nerve outer segment is taken up into the cell, phagocytic ability can be evaluated by observing the presence or absence of fluorescence in comparison with an acupuncture sheet without optic nerve outer segment added. As a result, fluorescence was observed only in the cultured ⁇ sheet with the optic nerve outer segment added, confirming that the cultured ⁇ sheet has phagocytic ability.
- the phagocytic ability of the cultured RPE sheet obtained in 3-6. was also evaluated in the same manner. As a result, fluorescence was observed only in the cultured RPE sheet with the nerve outer segment covered, and the phagocytic ability was confirmed.
- the iris pigment epithelial cells are black, and the area of the iris tissue from which the cells have been detached becomes a light skin color. Therefore, detachment of the cells is continued until the black area cannot be visually confirmed from the iris tissue.
- aspirate the solution with a pipette and inject it into a 15 ml centrifuge tube.
- After removing the supernatant add 5 ml of IPE culture solution, resuspend the pellet, and centrifuge at 4 ° C and 3000 rpm for 2 minutes. Collect the cell pellet by removing the supernatant.
- IPE medium unless otherwise specified for IPE cell culture. 7— Add lml of IPE medium to the tube containing the pellet obtained in step 2 to suspend the pellet, and add the whole solution to a 24 well plate (IWAKI) coated with type I collagen.
- IWAKI 24 well plate coated with type I collagen.
- One tissue worth of IPE cells is added to one tool. Cell culture is performed in an incubator with 5% CO and 37 ° C. After the culture, the medium is not changed, and the plate is left still. This is the period when IP E cells adhere to the plate, and the cells are observed daily. It takes about 7-10 days for the cells to adhere to the plate. After that, change the IPE medium every 3 days. The medium is exchanged according to the following procedure.
- a scleral incision is performed under local anesthesia for patients with informed consent.
- a vitrectomy is performed, and about 2 X 2 mm of healthy RPE is taken from the subretinal area sufficiently far from the macula.
- the excised tissue should be immersed in about 2 ml of intraocular perfusate, and the following treatment should be performed within 1 hour. If there is no other description, perform the subsequent processing with care for aseptic operation in a clean bench.
- the retinal pigment epithelial cells are black, and the area of the retina pigment tissue from which the cells have been detached becomes white. Therefore, detachment of the cells is continued until no black area can be visually confirmed from the retinal pigment tissue.
- aspirate the solution with a pipette and inject it into a 15 ml centrifuge tube.
- RPE cell culture Use RPE medium unless otherwise stated for RPE cell culture.
- 8- Add lml RPE medium to the tube containing the pellet obtained in step 2 to suspend the pellet, and add the whole solution to a 24-well plate (IWAKI) coated with type I collagen. This means that one tissue of RPE cells has been saved per tool.
- Cell culture is performed in an incubator with 5% CO and 37 ° C. After the culture, the medium is not changed, and the plate is left still. This is the time when RPE cells adhere to the plate, and the cells are observed daily. It takes about 7-10 days for the cells to adhere to the plate. After that, change the RPE medium every 3 days. Replace the medium in the same way as in 7-3. Cells become confluent about 3-4 weeks after the start of culture.
- Allogeneic IPE can be collected using an eyeball obtained from an eye bank. After removing the whole eyeball from the corpse, place it in an ocular storage solution such as optisol as soon as possible. Corneal limbal force About 5 mm outside is cut with scissors to separate the anterior ocular tissue including the cornea and the posterior ocular tissue including the retina. Anterior tissue force using cesi Remove the iris tissue except the cornea and lens. Iris pigment tissue can be obtained by thoroughly washing with BSS except for the jelly-like substance contained. Using the iris pigment tissue obtained in this way, prepare a cultured IPE sheet in the same manner as in 7-2 to 7_6.
- Allogeneic RPE can be collected using an eyeball obtained from an eye bank. After removing the whole eyeball from the cadaver, place it in an ophthalmic preservation solution such as optisol as soon as possible. Corneal limbal force About 5 mm outside is cut with scissors to separate the anterior ocular tissue including the cornea and the posterior ocular tissue including the retina. Remove the posterior ocular tissue force from the vitreous and retina using cesi, then retina pigmented membrane from the sclera And the choroid present on the sclera side is peeled to obtain a retinal pigment tissue. Retinal pigment tissue can be obtained by thorough washing with BSS. Using the retinal pigment tissue thus obtained, a cultured RPE sheet is prepared in the same manner as in 8_2 to 8_6.
- Transplantation of cultured IPE sheet or cultured RPE sheet can be carried out by the following procedure. First, after placing 2% methylcellulose on the recipient cornea, a contact lens for vitreous surgery is placed and a scleral incision is made at 11 o'clock. After vitrectomy, insert a 36G needle from the scleral incision to make a retinal incision at the lesion site. Artificial retinal detachment is made by injecting a small amount of intraocular perfusate from the retinal incision into the subretinal region. Spread the scleral incision and insert a cultured cell sheet (cultured IPE sheet or cultured RPE sheet) under the retina. After transplanting the cultured cell sheet, laser photocoagulation is performed on the retinal incision, and the lower eye is replaced with air or expandable gas. After transplanting, keep the prone position until air or gas is absorbed.
- a contact lens for vitreous surgery is placed and a scleral incision is made at 11 o'clock. After
- Dish coating for IPE primary culture In 2-3, the cells were cultured using a plasma-treated non-coated dish, a type IV collagen dish, a laminin coated dish, a fibronectin coated dish, or a matrigel coated dish instead of the type I collagen coated dish.
- a plasma-treated non-coated dish a type IV collagen dish
- a laminin coated dish a laminin coated dish
- a fibronectin coated dish or a matrigel coated dish instead of the type I collagen coated dish.
- the optimal carrier type for culture was examined using the number of adherent cells as an index.
- the number of adherent cells was almost the same as when using type I collagen coated dish.
- FCS concentration in the culture medium during primary culture was examined.
- 2 ⁇ 3 and 3 ⁇ 3 culture is performed under the condition that the concentration of FCS in the culture solution is reduced from 10% to 5, 3, 1, or 0%. The existence was observed.
- adherent cells were present, the number of adherent cells was compared with the FCS 10% condition.
- the number of adherent cells was the same as the condition of FCS 10% when FCS was 5% or more, and the number of adherent cells was slightly reduced under the condition of FCS 3%, F CS 1% or less Adherent cells were not observed under the conditions.
- the number of adherent cells was the same as FCS 10% when FCS was 3% or higher, slightly lower when FCS was 1%, and adherent cells were observed when FCS was 0%.
- the serum concentration in the culture medium during primary culture can be lowered to at least 3% in the case of IPE cells and to at least 1% in the case of RPE cells.
- a cultured cell sheet was prepared under the condition that the origin of collagen as a component of the substrate (collagen gel thin film) was swine, and the morphology of the cell layer was observed. Specifically, it was observed whether the cells constituting the cell layer had a honeycomb shape. As a result, it was found that even when a substrate made of porcine collagen was used, a culture sheet having a cell layer equivalent to that obtained when a substrate having collagen power derived from ushi was used. In other words, it was clarified that even a substrate prepared using collagen derived from other animal species as a raw material, not only from ushi, is useful for producing cultured cell sheets.
- the thickness of the substrate was changed from 20 ⁇ m to 10 am, and an attempt was made to produce a cultured cell sheet.
- both a substrate made of ushi collagen and a substrate made of porcine collagen were examined.
- a cultured cell sheet equivalent to the thickness of 2 ⁇ could be produced.
- the obtained cultured cell sheet had sufficient strength and form retention required for the transplant material.
- the thickness of the cultured cell sheet which has less physical space under the macular part retina to which the cultured cell sheet is transplanted, is 20 zm or less in total. From the above study, it became clear that a 10 ⁇ m-thick substrate could be used, and in fact, a cultured cell sheet with a thickness of 20 ⁇ m or less was successfully constructed.
- the cultured cell sheet of the present invention can be used as a transplant material for various diseases that require transplantation of retinal pigment epithelium (RPE).
- the cultured cell sheet of the present invention includes a cell layer having a structure similar to that of living body RPE.
- the cultured cell sheet of the present invention is formed by culturing and proliferating collected IPE cells or RPE cells in vitro. Therefore, it is possible to produce transplant material based on a small number of IPE cells or RPE cells, and even patients with a reduced number of these cells can make transplant material using their own cells. . This means that a network transplantation that does not cause rejection can be realized.
- the cultured cell sheet of the present invention can be constructed using autologous cells. If autologous cells are used, it can be said that a cell sheet that exhibits high engraftment and has an excellent therapeutic effect can be constructed.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Neurology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Vascular Medicine (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
明 細 書 Specification
培養細胞シート及びその作製方法 Cultured cell sheet and method for producing the same
技術分野 Technical field
[0001] 本発明は培養細胞シート及びその作製方法に関する。詳しくは、虹彩色素上皮細 胞又は網膜色素上皮細胞に由来する細胞層を備えた培養細胞シート及びその作製 方法に関する。本発明が提供する培養細胞シートは、網膜色素上皮の再建が必要と される網膜疾患、例えば加齢黄斑変性、網膜色素変性、糖尿病性網膜症、近視性 網脈絡膜萎縮、網膜色素腫瘍の治療における移植材料としてその利用が図られる。 背景技術 [0001] The present invention relates to a cultured cell sheet and a method for producing the same. Specifically, the present invention relates to a cultured cell sheet having a cell layer derived from iris pigment epithelial cells or retinal pigment epithelial cells and a method for producing the same. The cultured cell sheet provided by the present invention is used in the treatment of retinal diseases that require reconstruction of the retinal pigment epithelium, such as age-related macular degeneration, retinal pigment degeneration, diabetic retinopathy, myopic retina choroidal atrophy, and retinal pigment tumor. It can be used as a transplant material. Background art
[0002] 動物実験において、細胞増殖因子の一つである線維芽細胞増殖因子 (bFGF)力 骨の再生を加速することが報告されている。細胞増殖因子を利用して自己再生を人 為的に制御しょうとする一つの例である。また、虚血性心疾患などに対しては、同様 の手法を用いた臨床応用も始まっている。一方、眼科学分野でも再生医療が取り入 れられてきた。例えば、角膜上皮幹細胞や羊膜を利用して角膜上皮疾患を治療しよ うとする試みが行われている(非特許文献 1)。再生医療の進展によって、これまで治 療法がなかった疾患などにも積極的な治療が試みられてきている。一方、難治性の 網膜疾患となると、未だ確立された治療法がないばかりか、その病態についても不明 なものが多い。網膜疾患の中には、一旦発症すると重篤になるものが多数存在する。 臨床結果を評価できる段階ではなレ、ものの、難治性網膜疾患の代表である網膜色 素変性、加齢黄斑変性(age related macular degeneration : AMD)に対して、細胞移 植を利用した再生医療の適用が試みられている。 In animal experiments, it has been reported that fibroblast growth factor (bFGF), one of the cell growth factors, accelerates bone regeneration. This is one example of artificially controlling self-renewal using cell growth factors. For ischemic heart disease, clinical applications using similar methods have also begun. On the other hand, regenerative medicine has been introduced in the field of ophthalmology. For example, attempts have been made to treat corneal epithelial diseases using corneal epithelial stem cells and amniotic membrane (Non-patent Document 1). With the advancement of regenerative medicine, aggressive treatment has been tried for diseases that have not been treated before. On the other hand, for intractable retinal diseases, there are still no established treatments, and many of the conditions are unknown. There are many retinal diseases that become severe once they develop. Although it is not at the stage where clinical results can be evaluated, regenerative medicine using cell transplantation has been developed for retinal chromatic degeneration and age related macular degeneration (AMD), which are representative of intractable retinal diseases. Application is being attempted.
[0003] 加齢黄斑変性 (AMD)の中でも、 日本人に多いといわれる滲出型 AMDは、脈絡膜 新生血管板が黄斑部に形成されるために重篤な視力障害をきたし、時に、網膜下ま たは硝子体出血により急激な視力障害を引き起こす。従来、白人に多いといわれて いたが、中年以降に多発することもあって、国民の高齢化とともに日本人にも症例が 増加している。近年その原因となる網膜下新生血管に対し、硝子体とともにこれを除 去したり、黄斑部網膜を移動させる外科的治療や、特殊な化合物とレーザー光を用 レ、て新生血管を消退させることが試みられている。 [0003] Among age-related macular degeneration (AMD), wet AMD, which is said to be common among Japanese, causes severe visual impairment due to the formation of the choroidal neovascular plate in the macular region. Or vitreous hemorrhage causes sudden visual impairment. Traditionally, it was said to be more common among whites, but it often occurs after middle age, and the number of Japanese people is increasing as the population ages. In recent years, the subretinal neovascularization that causes it is removed together with the vitreous, surgical treatment to move the macular retina, and special compounds and laser light are used. Attempts have been made to eliminate new blood vessels.
[0004] 1970年代の網膜や網膜色素上皮(retinalpigment印 ithelium : RPE)の機能に関する 研究、 1980年代に発展した眼内免疲に関する研究、更にはそれらに基づく RPEや網 膜移植による視細胞保護効果に関する研究が盛んになり、患者に対して非自己色素 上皮細胞の移植や、未分化な胎児神経網膜の移植が試みられた。 RPEと虹彩色素 上皮細胞(irispigment印 ithelium : IPE)の分子生物学的手法を用いた比較、さらに RP Eの網膜下移植による視細胞変性阻止効果の観察が行われてきた。それらの基礎研 究、世界的な臨床研究、黄斑下新生血管膜の単純除去症例の臨床経過を総合し、 患者自身の IPEを採取し、患者自身の血清を用いて培養し、新生血管膜の除去手術 と同時に黄斑下に移植する方法が行われたが、 2年以上の経過観察で再発や副作 用は見られないものの視力回復は満足できるものではなレ、。 AMDに対して以前行わ れた、単純に脈絡膜新生血管(choroidal neovascularizatjon: CNV)の抜去だけを行 う手術とその成績の検討から、 CNVの抜去とともに脱落する RPE対策に、 自己の IPE を移植するという再生医療が試みられてきた。その結果、自己の IPEを培養して網膜 下に移植しても安全であることが判明した。しかし、視力予後の点からはさらに新しい 工夫が必要であると考えられた。 CNV抜去後に自己の IPEを移植する方法 (非特許 文献 2)は、 CNV抜去後に障害された網膜色素上皮の代用細胞として IPEを利用する ものであるが、その効果を考えると臨床応用には程遠い。 [0004] Research on the function of the retina and retinal pigment epithelium (retinalpigment mark ithelium: RPE) in the 1970s, research on intraocular fatigue developed in the 1980s, and further on the photoreceptor protection effect by RPE and retina transplantation based on them Research has been actively conducted, and transplantation of non-self-pigmented epithelial cells and undifferentiated fetal neural retina has been attempted for patients. Comparison of RPE and iris pigment epithelial cells (irispigment sign ithelium: IPE) using molecular biology techniques, and observation of the inhibitory effect of RPE by subretinal transplantation on photoreceptor degeneration. These basic studies, global clinical studies, and clinical courses of patients with simple removal of submacular neovascular membranes were collected, and the patient's own IPE was collected and cultured with the patient's own serum. At the same time as the removal operation, a method of transplanting under the macula was performed, but although no recurrence or side effects were observed after 2 years of follow-up, the visual recovery was not satisfactory. Transplanting own IPE to the RPE countermeasures that fall out with the removal of CNV, based on the results of previous surgery on AMD and simply removing choroidal neovascularizatjon (CNV) Regenerative medicine has been tried. As a result, it was found that it is safe to culture their own IPE and transplant it under the retina. However, from the viewpoint of visual acuity prognosis, it was considered that further innovation was necessary. The method of transplanting autologous IPE after CNV removal (Non-Patent Document 2) uses IPE as a surrogate cell for retinal pigment epithelium that has been impaired after CNV removal, but its effect is far from clinical application. .
[0005] 網膜色素上皮(RPE)の変性、脱落は脈絡膜毛細血管の変性萎縮を招いたり、直 接視細胞の変性に関与することが示されている。したがって、加齢黄斑変性 (AMD) で CNV抜去後、 RPEが脱落又は萎縮した領域に RPEあるいは RPEの代用になるもの を補い、視細胞の変性、消失を防ぐことが試みられてきた。これにはアイバンクから提 供された眼球の RPEや胎児の RPE、又は自己の IPEなどが利用された (非特許文献 3 〜7)。 [0005] Degeneration and loss of retinal pigment epithelium (RPE) has been shown to cause degeneration and atrophy of choroidal capillaries or directly to degeneration of photoreceptor cells. Therefore, after CNV removal due to age-related macular degeneration (AMD), attempts have been made to prevent the degeneration and disappearance of photoreceptor cells by supplementing RPE or a substitute for RPE in the area where RPE is lost or atrophyed. For this, eyeball RPE, fetal RPE, or own IPE provided by Eye Bank were used (Non-Patent Documents 3 to 7).
虹彩自体は中胚葉と神経外胚葉に由来するが、 IPEは神経外胚葉由来であって、 発生学的には RPEと起源が同じである。上述のように、臨床的に採取が容易な IPEも 、脱落した RPEの代用として RPE欠損部へ移植されている。し力 ながら治療効果とし て、これまでのところ最終視力に 0.4という上限があり、最終視力も術後最高視力も、 単純に CNVを抜去した患者群との間に有意差はなレ、。培養した IPEには色素がほと んど認められず、移植細胞を直接確認するのは難しい。従って、培養細胞を移植し た場合、術後の視機能と移植細胞の関係を論ずるのは難しい。一方、術中に IPEを 分離し、培養しないで直接網膜下に移植すると(iris translocation)、術後に色素のあ る IPE塊を確認できる。また、サルに培養自己 IPEを移植した後に組織学的な検討を すると、培養自己 IPEが、視細胞の外節を貪食している所見も確認でき、培養 IPEと RP Eの機能の類似性も報告されていることから、移植した IPEが RPE類似の機能を持つ 可能性は十分にあると考えられている。 IPE移植をしたにもかかわらず、術後の視力 において、 CNVを抜去した症例との間に有意差がみられない理由として、神経網膜 の問題や移植細胞の網膜下の分布、生着率、移植細胞の Viabilityなどの問題が考 えられている。 The iris itself is derived from the mesoderm and neuroectoderm, but IPE is derived from the neuroectoderm and is embryologically identical in origin to RPE. As described above, IPE, which is clinically easy to collect, has also been transplanted into the RPE deficient part as a substitute for the dropped RPE. However, as a therapeutic effect, there is an upper limit of 0.4 for the final visual acuity so far. There is no significant difference from the patient group who simply removed CNV. The cultured IPE shows almost no pigment and it is difficult to confirm the transplanted cells directly. Therefore, when transplanting cultured cells, it is difficult to discuss the relationship between postoperative visual function and transplanted cells. On the other hand, if IPE is isolated during surgery and transplanted directly under the retina without culturing (iris translocation), a pigmented IPE mass can be confirmed after surgery. In addition, histological examination after transplantation of cultured autologous IPE to monkeys confirmed that the cultured autologous IPE phagocytosed the outer segment of photoreceptor cells, and the similarities in the functions of cultured IPE and RPE. From the reported results, it is considered that the transplanted IPE has a possibility of having a function similar to RPE. Despite IPE transplantation, there is no significant difference in postoperative visual acuity from patients with CNV removal. Reasons for neuroretinal problems, subretinal distribution of transplanted cells, survival rate, Problems such as the viability of transplanted cells are considered.
[0006] 非特許文献 1 :中村隆宏、木下茂:目の再生医学における羊膜の位置付け,眼科手術 [0006] Non-Patent Document 1: Takahiro Nakamura, Shigeru Kinoshita: Position of amniotic membrane in eye regenerative medicine, ophthalmic surgery
15 : 5-9,2002 15: 5-9,2002
非特許文献 2 : Abe T. et al., Tohoku J Exp Med 191 :7-20,2000 Non-Patent Document 2: Abe T. et al., Tohoku J Exp Med 191: 7-20,2000
非特許文献 3 : Peyman GA. et al., Ophthalmic Surg 22: 102-108, 1991 Non-Patent Document 3: Peyman GA. Et al., Ophthalmic Surg 22: 102-108, 1991
非特許文献 4 : Algvere PV. et al., Graefes Arch Clin Exp Ophthalmol 235: 149-158, Non-Patent Document 4: Algvere PV. Et al., Graefes Arch Clin Exp Ophthalmol 235: 149-158,
1997 1997
非特許文献 5 : Weisz JM. et al, Retina 19:540-545, 1999 Non-Patent Document 5: Weisz JM. Et al, Retina 19: 540-545, 1999
非特許文献 6 : Abe T. et al. , Tohoku J Exp Med 189:295-305, 1999 Non-Patent Document 6: Abe T. et al., Tohoku J Exp Med 189: 295-305, 1999
非特許文献 7 : Thumann G. et al., Arch Ophthalmol 118: 1350-1355, 2000 Non-Patent Document 7: Thumann G. et al., Arch Ophthalmol 118: 1350-1355, 2000
非特許文献 8 : Del Priore LV. et al" Am J Ophthalmol 131 :472-480, 2001 Non-Patent Document 8: Del Priore LV. Et al "Am J Ophthalmol 131: 472-480, 2001
発明の開示 Disclosure of the invention
発明が解決しょうとする課題 Problems to be solved by the invention
[0007] 以上のように、網膜色素上皮(RPE)の再建のために様々な試みが行われている。 As described above, various attempts have been made to reconstruct the retinal pigment epithelium (RPE).
し力しながら、満足できる治療効果が得られていないのが現状である。そこで本発明 は、 RPEの代替として利用でき、高い治療効果(RPEの良好な再建)を発揮する移植 材料及びその作製方法提供することを課題とする。 However, the current situation is that a satisfactory therapeutic effect has not been obtained. Accordingly, an object of the present invention is to provide a transplant material that can be used as an alternative to RPE and that exhibits a high therapeutic effect (good reconstruction of RPE) and a method for producing the same.
課題を解決するための手段 本発明者らは以上の課題に鑑み鋭意検討を行った。まず、これまでの報告を踏ま えて、網膜色素上皮の再建に利用する細胞として虹彩色素上皮細胞(IPE細胞)又は 網膜色素上皮細胞(RPE細胞)が適当であると考えた。次に、生着率、操作性 (取り扱 いや移植が容易であること)、及び移植後の期待される機能の発揮の点に着目し、生 体の RPE同様に予め組織化された細胞、即ちモノレイヤー化した細胞(細胞シート) を移植することが好ましいと考えた。更に、細胞層の構築にはキャリアとしての基質が 必須となる力 高い治療効果が期待できる細胞シートを構築するための基質には以 下の特性、即ち (1)使用適用時に薄レ、こと、(2)強度が高いこと、(3)使用する細胞同士 の良好な接着性、及び使用する細胞と基質間の良好な接着性が得られること、並び に (4)その上に播種された細胞の機能を保持できることが要求されると考えた。これら の特性に着眼点をおき基質を模索したところ、ガラス化された薄膜状のコラーゲンゲ ル (コラーゲンゲル薄膜)が最適であることを見出した。特に、当該コラーゲンゲル薄 膜は、天然コラーゲンゃァテロコラーゲンなど一般的に流通しているコラーゲンで作 製したものに比較して、乾燥状態から湿潤状態に移行する際の膨潤がほとんどない という特徴を有し、これを基質とすれば極めて薄い培養細胞シートを構築可能である ことを見出した。検討を進め、実際に IPE細胞及び RPE細胞を用いてそれぞれ細胞層 の構築を試みたところ、当該基質の有用性が確認された。一方、コラーゲンゲル薄膜 の作製方法を工夫した結果、約 10 μ m以下のコラーゲンゲル薄膜を安定的に供給す ることに成功した。本発明は主として以上の知見に基づくものであって、以下の構成 を提供する。 Means for solving the problem The present inventors have conducted intensive studies in view of the above problems. First, based on previous reports, I thought that iris pigment epithelial cells (IPE cells) or retinal pigment epithelial cells (RPE cells) were appropriate as cells used for the reconstruction of the retinal pigment epithelium. Next, focusing on the engraftment rate, operability (easy to handle and transplant), and the function expected after transplantation, pre-organized cells, similar to living RPE, That is, it was considered preferable to transplant monolayered cells (cell sheet). In addition, the substrate as a carrier is indispensable for the construction of the cell layer. The substrate for constructing a cell sheet that can be expected to have a high therapeutic effect has the following characteristics: (1) (2) High strength, (3) Good adhesion between cells to be used, and good adhesion between cells to be used and substrate, and (4) Cells seeded on them We thought that it would be required to be able to maintain the functions of Looking at these characteristics and searching for a substrate, we found that a vitrified thin-film collagen gel (collagen gel thin film) was optimal. In particular, the collagen gel thin film has a feature that there is almost no swelling at the time of transition from a dry state to a wet state, as compared to a product made from a commonly distributed collagen such as natural collagen or collagen. It has been found that if this is used as a substrate, an extremely thin cultured cell sheet can be constructed. As the investigation proceeded and the construction of cell layers was attempted using IPE cells and RPE cells, the usefulness of the substrate was confirmed. On the other hand, as a result of devising a method for producing a collagen gel thin film, we succeeded in stably supplying a collagen gel thin film of about 10 μm or less. The present invention is mainly based on the above knowledge and provides the following configurations.
[1] 厚さが約 20 z m以下のガラス化処理されたコラーゲンゲル薄膜と、その上に形 成された、虹彩色素上皮細胞又は網膜色素上皮細胞由来の細胞層と、を備える培 養細胞シート。 [1] A cultured cell sheet comprising a vitrified collagen gel thin film having a thickness of about 20 zm or less, and an iris pigment epithelial cell or retinal pigment epithelial cell-derived cell layer formed thereon. .
[2] 前記コラーゲンゲル薄膜の厚さが約 5 μ πι〜約 10 z mである、 [1]に記載の培 養細胞シート。 [2] The cultured cell sheet according to [1], wherein the collagen gel thin film has a thickness of about 5 μπι to about 10 zm.
[3] 前記コラーゲンゲル薄膜が I型コラーゲンからなる、 [1]又は [2]に記載の培 養細胞シート。 [3] The cultured cell sheet according to [1] or [2], wherein the collagen gel thin film is made of type I collagen.
[4] 前記コラーゲンゲル薄膜に、その形状を維持するための支持体が付いている 、 [ 1]〜 [3]のレ、ずれかに記載の培養細胞シート。 [4] The collagen gel thin film has a support for maintaining its shape. The cultured cell sheet according to any one of [1] to [3].
[5] 以下のひ)〜 (8)からなる群より選択される一つ以上の特徴を備える、 [1]〜[4] のいずれかに記載の培養細胞シート: [5] The cultured cell sheet according to any one of [1] to [4], comprising one or more features selected from the group consisting of:
(1)前記細胞層が一層構造である; (1) the cell layer has a single layer structure;
(2)前記細胞層の細胞密度が約 1000〜 10000細胞/ mm2である; (2) the cell density of the cell layer is about 1000-10000 cells / mm 2 ;
(3)前記細胞層を構成する細胞の平面視形状が多角形型である; (3) The planar view shape of the cells constituting the cell layer is a polygonal shape;
(4)前記細胞層において細胞がほぼ均一に且つ規則正しく整歹している; (4) The cells are arranged almost uniformly and regularly in the cell layer;
(5)前記細胞層において細胞間にタイトジャンクションが認められる; (5) Tight junctions are observed between cells in the cell layer;
(6)前記細胞層が貪食能を備える; (6) the cell layer has phagocytic ability;
(7)前記細胞層においてメラニン色素の沈着が認められる; (7) melanin deposition is observed in the cell layer;
(8)前記細胞層において網膜色素上皮細胞マーカーの発現が認められる。 (8) Expression of a retinal pigment epithelial cell marker is observed in the cell layer.
[6] 前記 (1)〜(8)の特徴の全てを備える、 [5]に記載の培養細胞シート。 [6] The cultured cell sheet according to [5], comprising all of the features (1) to (8).
[7] 以下のステップを含む、培養細胞シートの作製方法: [7] A method for producing a cultured cell sheet comprising the following steps:
(1)厚さが約 20 / m以下のガラス化されたコラーゲンゲル薄膜を用意するステップ; (1) providing a vitrified collagen gel thin film having a thickness of about 20 / m or less;
(2)虹彩色素上皮細胞又は網膜色素上皮細胞を用意するステップ; (2) preparing iris pigment epithelial cells or retinal pigment epithelial cells;
(3)前記コラーゲンゲル薄膜上に前記細胞を播種し、培養するステップ; (3) seeding and culturing the cells on the collagen gel thin film;
(4)培養後、前記コラーゲンゲル薄膜と、その上に形成された細胞層とを回収するス テツプ。 (4) A step of recovering the collagen gel thin film and the cell layer formed thereon after culturing.
[8] 前記コラーゲンゲル薄膜の厚さが約 5 μ πι〜約 10 z mである、 [7]に記載の作 製方法。 [8] The production method according to [7], wherein the collagen gel thin film has a thickness of about 5 μπι to about 10 zm.
[9] 前記コラーゲンゲル薄膜が I型コラーゲンからなる、 [7]又は [8]に記載の作 製方法。 [9] The production method according to [7] or [8], wherein the collagen gel thin film is made of type I collagen.
[ 10] 前記コラーゲンゲル薄膜に、その形状を維持するための支持体が付いてい る、 [7]〜 [9]のいずれかに記載の作製方法。 [10] The production method according to any one of [7] to [9], wherein the collagen gel thin film is provided with a support for maintaining the shape thereof.
[11] 厚さが約 10 μ m以下のガラス化処理されたコラーゲンゲル薄膜からなる基質 図面の簡単な説明 [11] Substrate consisting of a vitrified collagen gel thin film with a thickness of about 10 μm or less
[図 1]ガラス化されたコラーゲンゲル薄膜の作製に使用される支持体を模式的に示す 図である。 [Fig. 1] Schematic representation of the support used to produce a vitrified collagen gel film FIG.
[図 2]コラーゲンゲル薄膜上に構築させた IPE細胞シートの実体顕微鏡写真を示す図 である。 FIG. 2 is a stereomicrograph of an IPE cell sheet constructed on a collagen gel thin film.
[図 3]コラーゲンゲル薄膜上に構築させた RPE細胞シートの実体顕微鏡写真を示す 図である。 FIG. 3 is a stereomicrograph of an RPE cell sheet constructed on a collagen gel thin film.
園 4]コラーゲンゲル薄膜上に構築させた IPE細胞シートにビーズを貪食させた実験 の結果 (実体顕微鏡写真)を示す図である。 FIG. 4 is a diagram showing the results (stereomicrograph) of an experiment in which beads were phagocytosed on an IPE cell sheet constructed on a collagen gel thin film.
園 5]コラーゲンゲル薄膜上に構築させた RPE細胞シートにビーズを貪食させた実験 の結果 (実体顕微鏡写真)を示す図である。 FIG. 5 is a diagram showing the results of an experiment in which beads were phagocytosed on an RPE cell sheet constructed on a collagen gel thin film (photomicrograph).
発明を実施するための最良の形態 BEST MODE FOR CARRYING OUT THE INVENTION
(用語) (the term)
用語「培養細胞シート」とは、生体から採取された所定の細胞を生体外で培養する ことによって形成された細胞層を備えるシート状構築物をいう。同様に、用語「培養 IP Eシート」とは、生体から採取された虹彩色素上皮細胞(IPE細胞)を生体外で培養す ることによって形成された細胞層を備えるシート状構築物をレ、い、用語「培養 RPEシ ート」とは、生体から採取された網膜色素上皮細胞(RPE細胞)を生体外で培養するこ とによって形成された細胞層を備えるシート状構築物をいう。 The term “cultured cell sheet” refers to a sheet-like construct comprising a cell layer formed by culturing predetermined cells collected from a living body in vitro. Similarly, the term “cultured IPE sheet” refers to a sheet-like construct comprising a cell layer formed by culturing iris pigmented epithelial cells (IPE cells) collected from a living body in vitro, The term “cultured RPE sheet” refers to a sheet-like construct comprising a cell layer formed by culturing retinal pigment epithelial cells (RPE cells) collected from a living body in vitro.
用語「虹彩色素上皮細胞(IPE細胞)」とは、特に記載のない限り、虹彩色素上皮に 由来する細胞を包括した表現として使用され、即ち虹彩色素上皮幹細胞をも含む。 同様に、用語「網膜色素上皮細胞(RPE細胞)」とは、特に記載のない限り、網膜色素 上皮に由来する細胞を包括した表現として使用され、即ち網膜色素上皮幹細胞をも 含む。 The term “iris pigment epithelial cells (IPE cells)” is used as a comprehensive expression of cells derived from the iris pigment epithelium unless otherwise specified, ie, includes iris pigment epithelial stem cells. Similarly, unless otherwise specified, the term “retinal pigment epithelial cell (RPE cell)” is used as a comprehensive expression of cells derived from the retinal pigment epithelium, that is, includes retinal pigment epithelial stem cells.
用語「虹彩色素上皮細胞由来の細胞層」とは、虹彩色素上皮細胞を培養すること によって構築される細胞層をいう。同様に、用語「網膜色素上皮細胞由来の細胞層」 とは、網膜色素上皮細胞を培養することによって構築される細胞層をいう。 The term “irid pigment epithelial cell-derived cell layer” refers to a cell layer constructed by culturing iris pigment epithelial cells. Similarly, the term “cell layer derived from retinal pigment epithelial cells” refers to a cell layer constructed by culturing retinal pigment epithelial cells.
用語「コラーゲンゲル」とは、多量の水を保有した網目状構造のコラーゲンをいい、 コラーゲンゾルをゲル化することで調製される。 The term “collagen gel” refers to collagen having a network structure containing a large amount of water, and is prepared by gelling a collagen sol.
用語「コラーゲンゲル乾燥体」とは、ガラス化される条件下でコラーゲンゲルを薄膜 状に乾燥して得られる物質をレ、う。 The term “collagen gel dry body” means that collagen gel is thinned under vitrified conditions. The substance obtained by drying into a shape is added.
用語「コラーゲンゲル薄膜」とは、コラーゲンゲル乾燥体を再水和させて得られるシ ート状構造体をいう。 The term “collagen gel thin film” refers to a sheet-like structure obtained by rehydrating a dried collagen gel.
用語「ガラス化」とは、乾燥させることで固くて透明な物質に変えることをレ、う (Takush i E., Edible eyeballs from fish. Nature 345, 298, 1990)。 The term “vitrification” refers to changing to a hard and transparent substance by drying (Takush i E., Edible eyeballs from fish. Nature 345, 298, 1990).
(培養細胞シート) (Cultivated cell sheet)
本発明の第 1の局面は培養細胞シートに関する。本発明の培養細胞シートは、 (1) 厚さが約 20 μ m以下のガラス化処理されたコラーゲンゲル薄膜と、(2)その上に形成さ れた、虹彩色素上皮細胞(IPE細胞)又は網膜色素上皮細胞(RPE細胞)由来の細胞 層とを備える。このように、本発明の培養細胞シートは、 IPE細胞又は RPE細胞胞由来 の細胞層の基質として、特定のコラーゲンゲル薄膜を利用していることを特徴の一つ とする。 The first aspect of the present invention relates to a cultured cell sheet. The cultured cell sheet of the present invention comprises (1) a vitrified collagen gel thin film having a thickness of about 20 μm or less, and (2) iris pigmented epithelial cells (IPE cells) or Cell layer derived from retinal pigment epithelial cells (RPE cells). Thus, the cultured cell sheet of the present invention is characterized by using a specific collagen gel thin film as a substrate for a cell layer derived from IPE cells or RPE cell vesicles.
一方、コラーゲンゲル薄膜上に形成された細胞層は、 IPE又は RPE由来の細胞によ つて構築されている。このことは、細胞層に含まれる細胞の形態、 IPE細胞(又は RPE 細胞)に特徴的なマーカー(例えばサイトケラチン、 RPE65、 CRALBP、 pP344、 Bestro phin)の発現の有無などを調べることによって確認することができる。 On the other hand, the cell layer formed on the collagen gel thin film is constructed of cells derived from IPE or RPE. This is confirmed by examining the morphology of cells contained in the cell layer and the presence or absence of expression of markers characteristic of IPE cells (or RPE cells) (eg cytokeratin, RPE65, CRALBP, pP344, Bestro phin). be able to.
細胞層は、好ましくは以下の特徴のいくつかを備え、特に好ましくは以下の全ての 特徴を備える。 The cell layer preferably has some of the following characteristics, particularly preferably all the following characteristics.
(1)細胞層が一層構造(単層構造)である。これは生体の IPE及び RPEが共通して備 える特徴の一つである。 (1) The cell layer has a single layer structure (single layer structure). This is one of the features that biological IPE and RPE have in common.
(2)生体の RPEの細胞密度は、約 3000〜約 5000細胞 Zmm2である。このことを考慮 すれば、本発明の細胞層における細胞密度は約 1000〜約 100000細胞 Zmm2である ことが好まし 約 2000〜約 8000細胞/ mm2であることがさらに好ましい。 (2) a cell density of RPE biological is about 3000 to about 5000 cells ZMM 2. In view of this, the cell density in the cell layer of the present invention is preferably about 1000 to about 100,000 cells Zmm 2 , more preferably about 2000 to about 8000 cells / mm 2 .
(3)細胞層を構成する細胞の平面視形状が多角形型である。これは生体における R PE細胞が備える特徴の一つである。この特徴が認められることにより、本発明の細胞 層は生体の網膜色素上皮に類似し、 RPEと同様の機能を発揮することが期待される (3) The planar view shape of the cells constituting the cell layer is a polygonal shape. This is one of the features of RPE cells in the body. By observing this feature, the cell layer of the present invention is expected to exhibit a function similar to that of RPE, similar to the retinal pigment epithelium of a living body.
(4)細胞層において細胞がほぼ均一に且つ規則正しく整列している。生体の RPEに おいてはそれを構成する細胞は均一に且つ規則正しく整列しており、これによつて網 膜—脈絡膜間での関門柵としての役割を持つ。したがって、このような形態的な特徴 を備えることにより、本発明の細胞層は生体における RPEと同様の機能を発揮するこ とが期待される。 (4) Cells are almost uniformly and regularly aligned in the cell layer. For living body RPE In this case, the cells constituting the cell are uniformly and regularly arranged, thereby serving as a barrier between the retina and the choroid. Therefore, by providing such morphological features, the cell layer of the present invention is expected to exhibit the same function as RPE in a living body.
(5)細胞層において細胞間にタイトジャンクションが認められる。タイトジャンクション の有無は、タイトジャンクション関連タンパク質である ZO-1の発現を調べることによつ て確認できる。 (5) Tight junctions are observed between cells in the cell layer. The presence or absence of tight junctions can be confirmed by examining the expression of tight junction-related protein ZO-1.
(6)前記細胞層が貪食能を備える。生体の RPE細胞はその貪食能によって視細胞の 代謝という重要な機能を発揮する。細胞層が貪食能を備えることによって、 RPE同様 の機能の発揮が期待される。 (6) The cell layer has phagocytic ability. Living RPE cells exert an important function of metabolism of photoreceptors by their phagocytic ability. As the cell layer has phagocytic ability, it is expected to exhibit the same functions as RPE.
(7)前記細胞層においてメラニン色素の沈着が認められる。網膜色素上皮細胞中の メラニンは網膜で吸収しきれなかった光を吸収することにより網膜を守る。細胞層がメ ラニンを有することによって、 RPEの網膜保護機能が期待される。 (7) Deposition of melanin pigment is observed in the cell layer. Melanin in retinal pigment epithelial cells protects the retina by absorbing light that could not be absorbed by the retina. Since the cell layer has melanin, RPE's retinal protective function is expected.
(8)前記細胞層において網膜色素上皮細胞マーカーの発現が認められる。 以下に本発明の培養細胞シート及びその作製方法の特徴を詳述する。 (8) Expression of a retinal pigment epithelial cell marker is observed in the cell layer. The characteristics of the cultured cell sheet of the present invention and the production method thereof will be described in detail below.
[0012] (培養細胞シートの作製方法) [0012] (Method for producing cultured cell sheet)
本発明における培養細胞シートの作製方法では次のステップひ)〜 (4)を実施する。 In the method for producing a cultured cell sheet according to the present invention, the following steps (i) to (4) are performed.
(1)厚さが約 20 μ m以下のガラス化されたコラーゲンゲル薄膜を用意するステップ (1) Step of preparing a vitrified collagen gel thin film with a thickness of about 20 μm or less
(2)虹彩色素上皮細胞(IPE細胞)又は網膜色素上皮細胞(RPE細胞)を用意するス テツプ (2) Step to prepare iris pigment epithelial cells (IPE cells) or retinal pigment epithelial cells (RPE cells)
(3)前記コラーゲンゲル薄膜上に前記細胞を播種し、培養するステップ (3) seeding and culturing the cells on the collagen gel thin film
(4)培養後、前記コラーゲンゲル薄膜と、その上に形成された細胞層とを回収するス テツプ (4) A step of recovering the collagen gel thin film and the cell layer formed thereon after culturing.
以下、各ステップの詳細を説明する。 Details of each step will be described below.
[0013] (1)コラーゲンゲル薄膜を用意するステップ [0013] (1) Step of preparing a collagen gel thin film
コラーゲンゲル薄膜は国際公開第 014774号公報(WO2005/014774A1)又は Cell transplantation, Vol.13,卯 .463-473, 2004に記載の方法に従って調製することがで きる。調製方法の概要を以下に示す (詳細については上記公報及び文献を参照)。 まず、所定濃度(例えば 0.5%(w/v))のコラーゲン水溶液 (例えば、 I型コラーゲン水 溶液)と、等量の緩衝液 (例えばリン酸系緩衝液)を混合する。このようにして得られた コラーゲンゾルを適当な容器 (例えば培養皿)に移し、保湿インキュベーター内で 37 °C、 5%CO条件下 2時間静置することでゲル化させる。続いて、容器を 10°C、 40%湿度 の条件下のクリーンベンチ内に移し、容器内を開放した状態で 2日間放置し、完全に 乾燥させる。これによつてコラーゲンゲルがガラス化する。このようにして得られたコラ 一ゲンゲル乾燥体はそのままの状態で、又は PBS等でのリンス及びその後の乾燥 (例 えば、上記乾燥処理と同条件で乾燥させる)を得た後に、室温で無菌的にコラーゲン ゲル乾燥体として保管維持する。この保管維持の時間を十分に確保することによって 、強度の増強を図れる。コラーゲンゲル乾燥体を適当な液体 (例えば生理食塩水、 P BS等の緩衝液、培養液)で湿潤状態に戻すこと(再水和)によってコラーゲンゲル薄 膜が得られる。 The collagen gel thin film can be prepared according to the method described in International Publication No. 014774 (WO2005 / 014774A1) or Cell transplantation, Vol. 13, 卯 .463-473, 2004. The outline of the preparation method is shown below (for details, see the above publication and literature). First, a collagen aqueous solution (for example, type I collagen aqueous solution) having a predetermined concentration (for example, 0.5% (w / v)) and an equal amount of buffer solution (for example, phosphate buffer) are mixed. The collagen sol thus obtained is transferred to a suitable container (for example, a culture dish) and allowed to gel by allowing it to stand in a moisturizing incubator at 37 ° C. under 5% CO for 2 hours. Subsequently, the container is transferred to a clean bench under conditions of 10 ° C and 40% humidity, and left for 2 days with the container open to dry completely. As a result, the collagen gel is vitrified. The dried collagen gel thus obtained is left as it is or after rinsing with PBS or the like and subsequent drying (for example, drying under the same conditions as the above drying treatment), and then aseptic at room temperature. Store and maintain as a dried collagen gel. By securing sufficient storage and maintenance time, the strength can be increased. A collagen gel thin film can be obtained by returning the dried collagen gel to a wet state (rehydration) with an appropriate liquid (for example, a physiological saline, a buffer solution such as PBS, or a culture solution).
本発明ではガラス化処理されたコラーゲンゲル薄膜が使用される。ガラス化処理さ れたコラーゲンゲル薄膜は強度に優れ、透明度も高い。また、乾燥状態から湿潤状 態に移行する際の膨潤が極めて少なぐ使用時 (湿潤状態)において極めて薄い状 態にできる。これに対して、ガラス化処理されていない通常のコラーゲンシート (例え ば特開 2005— 229869号公報に開示される I型コラーゲンシート)は 3〜5倍程度に 膨潤する。このことと、現在の技術レベルでは、通常のコラーゲンシートの乾燥体とし て 10 μ m程度の厚さのものを製造するのが限界であることを考え合わせれば、従来の コラーゲンシートでは使用時に乾燥体の 3〜5倍の厚さ、即ち 30 μ π!〜 50 μ m程度に なってしまう。このように厚いコラーゲンシートは、物理的なスペースに乏しい網膜下 に移植される培養細胞シートの基質としての適格を欠く。以上の説明から明らかなよ うに、乾燥状態から湿潤状態に移行する際の膨潤が極めて少なぐそれ故に使用時 に極めて薄い状態にできる点は、培養細胞シート用の基質として使用する場合にお ける、コラーゲンゲル薄膜の最大の利点といえる。 In the present invention, a vitrified collagen gel thin film is used. A vitrified collagen gel thin film has excellent strength and high transparency. In addition, it can be made extremely thin during use (wet state) with very little swelling during the transition from the dry state to the wet state. In contrast, a normal collagen sheet that has not been vitrified (for example, a type I collagen sheet disclosed in JP-A-2005-229869) swells about 3 to 5 times. Considering this and the fact that it is the limit to produce a normal collagen sheet with a thickness of about 10 μm at the current technical level, conventional collagen sheets can be dried at the time of use. 3 to 5 times the thickness of the body, ie 30 μπ! ~ 50 μm. Such a thick collagen sheet lacks qualification as a substrate for cultured cell sheets that are transplanted under the retina where physical space is scarce. As is clear from the above explanation, the swelling at the time of transition from the dry state to the wet state is very small. Therefore, the extremely thin state can be obtained at the time of use when used as a substrate for a cultured cell sheet. This is the biggest advantage of the collagen gel thin film.
一方、後述の実施例に示すように、本発明者らの検討の結果、ガラス化処理された コラーゲンゲル薄膜上に、 IPE細胞及び RPE細胞のいずれも良好に接着するとともに 細胞同士の接着性も良好であった。また、高い細胞増殖効率も得られ、しかも播種さ れた細胞の機能が保持されることが判明した。以上のように、ガラス化処理されたコラ 一ゲンゲル薄膜は、 IPE細胞由来の細胞層又は RPE細胞由来の細胞層を構築する ための基質として好ましい特性を数多く備えることが明らかとなった。そして、ガラス化 処理されたコラーゲンゲル薄膜を使用して得られる培養細胞シート(培養 IPEシート又 は培養 RPEシート)は移植に適合する強度を保持しており、取り扱い易ぐ高い治療 効果も期待できるものとなる。 On the other hand, as shown in the examples described later, as a result of the study by the present inventors, both the IPE cells and the RPE cells adhere well to the vitrified collagen gel thin film, and the adhesion between cells is also improved. It was good. In addition, high cell growth efficiency can be obtained and seeded. It was found that the function of the cells retained was retained. As described above, it was revealed that the vitrified collagen gel thin film has many characteristics preferable as a substrate for constructing a cell layer derived from IPE cells or a cell layer derived from RPE cells. A cultured cell sheet (cultured IPE sheet or cultured RPE sheet) obtained using a vitrified collagen gel thin film retains strength suitable for transplantation, and can be expected to have a high therapeutic effect that is easy to handle. It will be a thing.
[0015] 本発明で使用されるコラーゲンゲル薄膜の厚さは約 20 z m以下である。このように 非常に薄いコラーゲンゲル薄膜を使用することによって、 RPE移植術に適した、極め て薄い培養細胞シートが構築される。ここで、培養細胞シートが移植されることになる 眼球内膜部は物理的なスペースに乏しい。従って、キャリアとしての基質はできるだ け薄い方がよい。一方で、基質には細胞層を支持するための十分な強度が要求され る。これらの点を考慮すれば、基質としてのコラーゲンゲル薄膜の厚さは好ましくは約 5 μ m~7j¾¾20 μ m,更に好ましくは約 5 μ m〜約 15 μ m以下であり、より一層好ましくは 約 5 μ m〜約 10 μ mである。 [0015] The thickness of the collagen gel thin film used in the present invention is about 20 zm or less. By using such a very thin collagen gel thin film, an extremely thin cultured cell sheet suitable for RPE transplantation is constructed. Here, the intimal part of the eyeball to which the cultured cell sheet is transplanted is scarce in physical space. Therefore, the substrate as a carrier should be as thin as possible. On the other hand, the substrate is required to have sufficient strength to support the cell layer. Considering these points, the thickness of the collagen gel thin film as a substrate is preferably about 5 μm to 7j¾¾20 μm, more preferably about 5 μm to about 15 μm, and still more preferably about 5 μm to about 10 μm.
[0016] コラーゲンゲル薄膜を構成するコラーゲンの種類、由来は特に限定されない。コラ 一ゲンの種類としては I型コラーゲン、 III型コラーゲン、 IV型コラーゲン、 VIII型コラー ゲンなどが挙げることができる。複数の種類のコラーゲンが混在した状態でコラーゲ ンゲル薄膜が構築されてレ、てもよレ、。 [0016] The type and origin of collagen constituting the collagen gel thin film are not particularly limited. Collagen types include type I collagen, type III collagen, type IV collagen, type VIII collagen and the like. A collagen gel thin film is constructed in a state where multiple types of collagen are mixed.
I型コラーゲンによって(又は主要成分を I型コラーゲンとして)コラーゲンゲル薄膜が 構成されていることが好ましい。 I型コラーゲンからなるコラーゲンゲル薄膜上では IPE 細胞及び RPE細胞の極めて良好な増殖が認められるとともに(後述の実施例を参照) 、 I型コラーゲンは安定供給が容易だからである。 It is preferable that the collagen gel thin film is composed of type I collagen (or main component is type I collagen). This is because very good growth of IPE cells and RPE cells is observed on a collagen gel thin film made of type I collagen (see Examples below), and type I collagen is easy to supply stably.
コラーゲンの由来としてはゥマ、ゥシ、ブタ、ヒッジ、サル、チンパンジー、及びヒトを 例示できる。また、遺伝子組換え技術で調製した(リコンビナント)ヒトコラーゲンを使 用してもよレ、。中でもリコンビナントヒトコラーゲン、ゥマ、ゥシ、又はブタ由来のコラー ゲンであることが好ましレ、。入手が容易だからである。 Examples of the origin of collagen include horse, ushi, pig, hidge, monkey, chimpanzee, and human. You can also use (recombinant) human collagen prepared by gene recombination technology. Of these, collagen from recombinant human collagen, horse, ushi, or pig is preferred. This is because it is easy to obtain.
[0017] コラーゲンゲル薄膜に生理活性物質が添加されていてもよい。ここでの生理活性物 質としては、細胞増殖因子、分化誘導因子、細胞接着因子、サイト力イン、血管新生 阻害因子、鎮痛消炎剤等を例示できる。異なる生理活性物質を組み合わせて添加し てもよい。 [0017] A physiologically active substance may be added to the collagen gel thin film. Physiologically active substances here include cell growth factor, differentiation-inducing factor, cell adhesion factor, site force in, angiogenesis Inhibitors, analgesic anti-inflammatory agents and the like can be exemplified. Different physiologically active substances may be added in combination.
[0018] 培養細胞シートの取り扱レ、の点及び移植後の形態保持の点などから、コラーゲンゲ ル薄膜の強度は原則として高いほどよい。そこで好ましくは、ガラス化処理前の状態( コラーゲンゲル)に比較して圧縮破壊強度力 ¾倍〜 20倍 (以下の測定条件で測定した 場合、約 100g〜約 800g程度)であるコラーゲンゲル薄膜が使用される。この条件を満 たすコラーゲンゲル薄膜は、常温での乾燥時の保管維持を約 40日以上行うことによ つて得ることが可能である。含有するコラーゲンのゲルィ匕を均一化するためには、ゲ ルイ匕過程を 15°Cや 4°Cなどに制御して行うことが望ましい。また、乾燥は常温での風 乾が望ましいが、減圧乾燥、凍結乾燥など当該分野で行われる方法を用いることが できる。細部の条件は製造されるコラーゲンゲル薄膜の強度、透明度、均一性、細胞 接着性、薄膜製造時の容器力らの剥離の容易性を指標として適宜変更することが可 能である。 [0018] In principle, the higher the strength of the collagen gel thin film, the better from the viewpoint of handling the cultured cell sheet and maintaining the shape after transplantation. Therefore, preferably, a collagen gel thin film having a compressive fracture strength of ¾ times to 20 times (about 100 g to about 800 g when measured under the following measurement conditions) as compared to the state before vitrification (collagen gel). used. A collagen gel thin film that satisfies this condition can be obtained by keeping it for about 40 days or more when it is dried at room temperature. In order to homogenize the gelation of the collagen contained, it is desirable to control the gelling process at 15 ° C or 4 ° C. In addition, air drying at normal temperature is desirable for drying, but a method performed in this field such as reduced pressure drying or freeze drying can be used. Detailed conditions can be changed as appropriate using the strength, transparency, uniformity, cell adhesion, and ease of peeling of container force during the production of the collagen gel thin film as indices.
[0019] <圧縮破壊強度の測定条件 > <Measurement conditions for compressive fracture strength>
日本電産工業株式会社製の強度測定機 (デジタルフォースゲージ)に接触面積 1.1 Contact area with Nidec Kogyo's strength measuring machine (digital force gauge) 1.1
3cm2の円形アダプターを取りつけ、 9mm/minの速度で薄膜を押し、薄膜破断時の最 大負荷を測定する。 Attach a 3 cm 2 circular adapter, press the thin film at a speed of 9 mm / min, and measure the maximum load when the thin film breaks.
[0020] 一方、培養細胞シートの透明度を高めて高い治療効果を発揮させるため、コラーゲ ンゲル薄膜の透明度は高いほどよい。そこで好ましくは、ガラス化処理前の状態(コラ 一ゲンゲル)に比較して 400nmにおける吸光度が 10%〜70% (吸光度約 0.1〜0.2程 度)であるコラーゲンゲル薄膜が使用される。この条件を満たすコラーゲンゲル薄膜 は、乾燥後の保管維持を約 40日以上行うことによって得ることが可能である。ゲル化 過程を 15°Cや 4°Cなどに制御して行うこともできる。また、常温での風乾が望ましいが 、減圧乾燥、凍結乾燥など当該分野で行われる方法を用レ、ることができる。 [0020] On the other hand, the higher the transparency of the collagen gel thin film, the better, in order to increase the transparency of the cultured cell sheet to exert a high therapeutic effect. Therefore, preferably, a collagen gel thin film having an absorbance at 400 nm of 10% to 70% (absorbance of about 0.1 to 0.2) as compared to the state before vitrification (collagen gel) is used. A collagen gel thin film satisfying this condition can be obtained by storing and maintaining after drying for about 40 days or more. The gelation process can be controlled at 15 ° C or 4 ° C. In addition, although air drying at normal temperature is desirable, a method performed in this field such as reduced pressure drying or freeze drying can be used.
[0021] ここで、本発明では支持体が付いたコラーゲンゲル薄膜を用意することが好ましレ、 。支持体の使用によって、コラーゲンゲル薄膜の形態を維持することができる。同時 に、薄膜製造時の容器からの剥離が容易となる。その結果、以下の細胞播種時又は 培養中におけるコラーゲンゲル薄膜の平坦性の確保及び維持を図ることができ、細 胞の接着性、増殖性、組織化が良好となり、高品質の細胞層が構築される。また、形 成された細胞層をコラーゲンゲル薄膜とともに回収する際、支持体をピンセットで掴 む等して比較的容易にコラーゲル薄膜を培養容器から剥離することができる。つまり 、支持体を用いることによって、作製された培養細胞シートを回収する際の操作性も 向上する。更には、支持体によってその形態を維持した状態で培養細胞シートを回 収できることから、形成された細胞層を損傷することなぐ移植器具に移動できる。し 力も移植に適した平坦性の高い培養細胞シートを得ることができる。 [0021] Here, in the present invention, it is preferable to prepare a collagen gel thin film with a support. By using the support, the morphology of the collagen gel thin film can be maintained. At the same time, peeling from the container during the production of the thin film becomes easy. As a result, it is possible to ensure and maintain the flatness of the collagen gel thin film at the time of cell seeding or during the following culture. Cell adhesion, proliferation, and organization are improved, and a high-quality cell layer is constructed. Further, when the formed cell layer is recovered together with the collagen gel thin film, the collage gel thin film can be peeled off from the culture vessel relatively easily by grasping the support with tweezers. That is, by using the support, the operability when collecting the prepared cultured cell sheet is improved. Furthermore, since the cultured cell sheet can be collected while maintaining its shape by the support, it can be transferred to a transplantation device without damaging the formed cell layer. However, a highly flat cultured cell sheet suitable for transplantation can also be obtained.
[0022] 支持体が付いたコラーゲンゲル薄膜は例えば以下の手順で用意することができる。 [0022] The collagen gel thin film with the support can be prepared, for example, by the following procedure.
まず、支持体としてドーナツ状に成形したナイロン膜を用意する。次にナイロン膜を培 養皿に入れる。その後、上述した通りの手順で、コラーゲンゾルの調製及び培養皿へ の添加、ゲル化、及びガラス化を実施する。以上の工程を得て、外周部分の片面側 に支持体が付着したコラーゲンゲル薄膜が完成する。 First, a nylon membrane molded into a donut shape is prepared as a support. Next, put the nylon membrane into the culture dish. Thereafter, collagen sol is prepared and added to the culture dish, gelled, and vitrified by the procedure described above. With the above steps, a collagen gel thin film having a support attached on one side of the outer peripheral portion is completed.
支持体の材質として、ナイロンなどの合成繊維 (合成樹脂)、綿などの天然繊維、ポ リ乳酸などの生体吸収性材料、及び金属を例示することができる。一方、支持体の形 状は好ましくは環状(円、楕円、四角等)である。 Examples of the material of the support include synthetic fibers (synthetic resins) such as nylon, natural fibers such as cotton, bioabsorbable materials such as polylactic acid, and metals. On the other hand, the shape of the support is preferably circular (circle, ellipse, square, etc.).
支持体が付いたコラーゲンゲル薄膜を用いて形成された培養細胞シートの場合、 培養細胞シートを患者に移植する前 (培養細胞シートの調製後から培養細胞シート の移植直前までの間)に支持体が除去される。 In the case of a cultured cell sheet formed using a collagen gel thin film with a support, the support is used before transplanting the cultured cell sheet to the patient (from the preparation of the cultured cell sheet to immediately before transplantation of the cultured cell sheet). Is removed.
[0023] (2)細胞(IPE細胞又は RPE細胞)を用意するステップ [0023] (2) Step of preparing cells (IPE cells or RPE cells)
(a)IPE細胞 (a) IPE cells
(a_l)IPE細胞の採取 (a_l) IPE cell collection
IPE細胞はレシピエント自身又は適当なドナーの虹彩から常法で採取することがで きる。例えば、まず局所麻酔下で周辺虹彩切除術を行い、虹彩片を採取する。採取 した虹彩片より、トリプシン処理や用手的方法で上皮細胞を分離する。分離した上皮 細胞(IPE細胞)を、必要に応じて、 IPE細胞が成育できる適当な培養液中で培養する 。培養液としては例えば市販の F12培地に血清、抗生物質 (アンフォテリシン、ゲンタ マイシン、ペニシリン、ストレプトマイシンなど)などを添カ卩した培地を使用することがで きる。 [0024] 培地中に添加する血清としては、ヒト血清、牛胎仔血清、羊血清などを用いることが できる。中でも、同種由来の血清 (ヒト血清)を使用する力、 自家血清 (即ちレシピエン ト自身の血清)を使用することが好ましい。勿論、可能であれば、免疫拒絶反応の惹 起のおそれがなくなる自家血清を使用することが最も好ましい。たとえば、市販の Epi Life™ (カスケード社)、 MCDB153培地(日水製薬株式会社)やこれらの培地のァミノ 酸組成等を改変して作製される培地などのような異種動物由来の蛋白成分を全く含 有しない無血清培地を用いることもできる。即ち、本発明における培養方法として無 血清培養法を採用してもよい。このような態様では、血清由来の成分の混入による免 疫拒絶等の問題を回避することができる。 IPE cells can be collected routinely from the recipient himself or from the iris of a suitable donor. For example, first, a peripheral iris excision is performed under local anesthesia, and an iris piece is collected. Epithelial cells are separated from the collected iris pieces by trypsinization or manual methods. The separated epithelial cells (IPE cells) are cultured in an appropriate culture medium in which IPE cells can grow as necessary. As the culture solution, for example, a commercially available F12 medium supplemented with serum, antibiotics (amphotericin, gentamicin, penicillin, streptomycin, etc.) and the like can be used. [0024] As serum to be added to the medium, human serum, fetal bovine serum, sheep serum and the like can be used. Among them, the ability to use serum derived from the same species (human serum), it is preferable to use autologous serum (ie, the recipient's own serum). Of course, if possible, it is most preferable to use autologous serum that eliminates the risk of causing immune rejection. For example, protein components derived from heterologous animals such as commercially available Epi Life ™ (Cascade), MCDB153 medium (Nissui Pharmaceutical Co., Ltd.), and media prepared by modifying the amino acid composition of these mediums are completely removed. A serum-free medium containing no serum can also be used. That is, a serum-free culture method may be employed as the culture method in the present invention. In such an embodiment, problems such as rejection of immunity due to contamination of serum-derived components can be avoided.
[0025] 培養容器 (培養皿)にはその表面に I型コラーゲン、 IV型コラーゲン、フイブロネクチ ン、又はラミニンなどをコーティングしてあるものを使用することが好ましい。 IPE細胞 の培養容器表面への接着が促され、良好な増殖が行われるからである。特に、 I型コ ラーゲン、 IV型コラーゲン、又はフイブロネクチンがコートしてある培養容器を使用す ることが好ましい(後述の実施例を参照)。あるいは、合成高分子などの表面がナノテ クノロジー技術で処理されて IPE細胞の増殖に適する界面構造を有する素材を用い ることちでさる。 [0025] It is preferable to use a culture container (culture dish) whose surface is coated with type I collagen, type IV collagen, fibronectin, laminin or the like. This is because adhesion of IPE cells to the surface of the culture container is promoted, and good growth is performed. In particular, it is preferable to use a culture vessel coated with type I collagen, type IV collagen, or fibronectin (see Examples below). Alternatively, the surface of a synthetic polymer or the like is treated with a nanotechnology technique and a material having an interface structure suitable for IPE cell growth is used.
[0026] IPE細胞を培養する際の温度条件は IPE細胞が成育する限りにおいて特に限定さ れないが例えば、約 25°C〜約 45°C、増殖効率を考慮すれば好ましくは約 30°C〜約 4 0°C、更に好ましくは約 37°Cである。後に継代培養を行う場合の培養時間(即ち初代 培養の時間)は、使用する細胞の状態などによっても異なるが例えば 1〜60日間であ る。 [0026] The temperature conditions for culturing IPE cells are not particularly limited as long as the IPE cells grow. For example, about 25 ° C to about 45 ° C, preferably about 30 ° C in consideration of the growth efficiency. To about 40 ° C, more preferably about 37 ° C. The culture time (that is, the time of primary culture) for subsequent subculture is, for example, 1 to 60 days, although it varies depending on the state of the cells used.
ここで、利用可能な場合にはレシピエント自身の IPE細胞を用いることが好ましい。 移植に供した際に免疫拒絶反応の惧れが無い培養 IPEシートの作製が可能となり、 即ち免疫拒絶反応を伴わない移植術が可能となるからである。レシピエント自身の IP E細胞が入手できないか或は入手が困難な場合にはレシピエント以外の IPE細胞を 用いることもできるが、この場合には免疫適合性を考慮してドナーを選択することが 好ましい。 Here, when available, it is preferable to use the recipient's own IPE cells. This is because it is possible to produce a cultured IPE sheet that does not cause immune rejection when transplanted, that is, transplantation without immune rejection becomes possible. If the recipient's own IPE cells are not available or difficult to obtain, non-recipient IPE cells can be used, but in this case the donor should be selected in consideration of immunocompatibility. preferable.
[0027] (a-2)継代培養、細胞浮遊液の調製 培養に供された IPE細胞が増殖した後に継代培養を行うことができる。好ましくはサ ブコンフルェントなレ、しコンフルェントになった時点で継代培養を行う。継代培養は 次のように行うことができる。まず細胞培養液を除去後、 PBS (-)液にて細胞を洗浄の 後、トリプシン- EDTA等で処理することによって細胞を培養容器表面から剥がし、次 レ、で細胞を回収する。回収した細胞に培養液を加えて細胞浮遊液とする。 [0027] (a-2) Subculture, cell suspension preparation Subculture can be performed after the IPE cells subjected to culture have proliferated. Preferably, subculture is performed when subconfluent and confluent. Subculture can be performed as follows. First, after removing the cell culture medium, the cells are washed with PBS (−) solution, treated with trypsin-EDTA or the like to peel the cells from the surface of the culture container, and the cells are collected in the next step. A culture solution is added to the collected cells to prepare a cell suspension.
細胞浮遊液は上記の初代培養と同様に培養容器に播種され、培養に供される。継 代培養は上記の初代培養と同様の培養条件で行うことができる。培養時間は使用す る細胞の状態などによっても異なるが例えば 1〜60日間である。以上の継代培養は 必要に応じて複数回行うことができる。継代培養を繰り返すことにより細胞数を増加で き、また細胞密度の高い細胞浮遊液を調製することができる。最終的に約 2万細胞/ ml〜 10万細胞/ mlの細胞密度を有する細胞浮遊液を調製することが好ましい。 The cell suspension is seeded in a culture vessel in the same manner as in the primary culture described above and used for culture. Subculture can be performed under the same culture conditions as the above primary culture. The culture time varies depending on the state of the cells used and is, for example, 1 to 60 days. The above subculture can be performed multiple times as necessary. By repeating subculture, the number of cells can be increased and a cell suspension with a high cell density can be prepared. It is preferable to finally prepare a cell suspension having a cell density of about 20,000 cells / ml to 100,000 cells / ml.
[0028] (b)RPE細胞 [0028] (b) RPE cells
(b-l)RPE細胞の採取 (b-l) RPE cell collection
RPE細胞はレシピエント自身又は適当なドナーの周辺部網膜下から常法で採取す ることができる。例えば、まず局所麻酔下、強膜切開を実施し、黄斑部より十分に離 れた周辺部網膜下の網膜色素上皮を切除する。採取した網膜色素上皮片より、トリ プシン処理や用手的方法で上皮細胞を分離する。分離した上皮細胞 (RPE細胞)を、 必要に応じて、 RPE細胞が成育できる適当な培養液中で培養する。培養液としては 例えば市販の DMEM培地に血清、抗生物質(アンフォテリシン、ゲンタマイシン、ぺニ シリン、ストレプトマイシンなど)などを添加した培地を使用することができる。 RPE cells can be collected in a conventional manner from the recipient itself or from the subretinal area of a suitable donor. For example, a scleral incision is first performed under local anesthesia, and the retinal pigment epithelium under the peripheral retina sufficiently separated from the macula is removed. Epithelial cells are separated from the collected retinal pigment epithelium by trypsin treatment or manual method. The separated epithelial cells (RPE cells) are cultured in an appropriate culture medium in which RPE cells can grow as necessary. As the culture medium, for example, a medium obtained by adding serum, antibiotics (amphotericin, gentamicin, penicillin, streptomycin, etc.) to a commercially available DMEM medium can be used.
(b-2)継代培養、細胞浮遊液の調製 (b-2) Passage culture, cell suspension preparation
RPE細胞の継代、細胞浮遊液の調製は、 IPEと同様の手順及び条件で行うことがで きる。 RPE cell passages and cell suspensions can be prepared using the same procedures and conditions as for IPE.
[0029] 以上で説明したステップ (1)とステップ (2)は独立して実施される。従って、いずれの ステップを先に(又は両者を同時に)行ってもよいといえる力 各ステップで扱う材料( 即ち、コラーゲン、細胞)の性質を考慮すれば、通常は、コラーゲンゲル薄膜の用意 を先行して実施する。 [0029] Step (1) and step (2) described above are performed independently. Therefore, the power to say that any step can be performed first (or both at the same time). Considering the nature of the material (ie, collagen, cells) handled in each step, the preparation of the collagen gel thin film is usually preceded. And implement.
[0030] (3)細胞を播種及び培養するステップ このステップでは、上記の手順で調製した細胞(IPE細胞又は RPE細胞)を、上記の 手順で調製したコラーゲンゲル薄膜上に播種する。具体的には例えば、培養容器内 に調製したコラーゲンゲル乾燥体に培養液を添加し、インキュベート(例えば 37°C、 5 分〜 20分程度)する。このようにして得られた、ガラス化されたコラーゲンゲル薄膜上 に細胞浮遊液を播種する。この際、最終的に作製される培養細胞シートにおいて所 望の細胞密度の細胞層が形成されるように播種する細胞数を調整することが好まし レ、。具体的には細胞密度が約 1000〜約 10000細胞 Zmm2の細胞層が形成されるよう に例えば、 1 mm2あたり約 100個〜約 5000個、好ましくは約 500個〜 1000個の細胞を 播種する。培養は上記の初代培養などと同様の条件で行うことができる。培養時間は 使用する細胞の状態などによっても異なるが例えば 1日〜60日である。 [0030] (3) Step of seeding and culturing cells In this step, the cells (IPE cells or RPE cells) prepared by the above procedure are seeded on the collagen gel thin film prepared by the above procedure. Specifically, for example, a culture solution is added to a dried collagen gel prepared in a culture vessel and incubated (for example, 37 ° C, about 5 to 20 minutes). The cell suspension is seeded on the vitrified collagen gel thin film thus obtained. At this time, it is preferable to adjust the number of cells to be seeded so that a cell layer having a desired cell density is formed in the finally prepared cultured cell sheet. Specifically, for example, about 100 to about 5000 cells, preferably about 500 to 1000 cells are seeded per 1 mm 2 so that a cell layer with a cell density of about 1000 to about 10,000 cells Zmm 2 is formed. To do. The culture can be performed under the same conditions as the primary culture described above. The culture time varies depending on the state of the cells used, but is, for example, 1 day to 60 days.
[0031] ここでの細胞培養は、異種動物細胞非存在下で行うことが好ましい。本発明におい て「異種動物細胞非存在下」とは、 IPE細胞又は RPE細胞を培養する際の条件として 、当該細胞に対して異種である動物の細胞が使用されないことをいう。具体的には IP E細胞又は RPE細胞としてヒトの細胞を使用する場合に、マウスやラット等、ヒト以外の 動物種の細胞が培養液中に存在(併存)しない条件のことをいう。このような条件で培 養を実施することによって、最終的に得られる移植材料 (即ち培養細胞シート)の細 胞成分に異種由来の成分 (異種細胞自体を含む)が混入するおそれがなくなる。尚、 初代培養(及び必要に応じた継代培養)についても、異種動物細胞非存在下で行わ れることが好ましい。 [0031] The cell culture here is preferably performed in the absence of heterologous animal cells. In the present invention, “in the absence of heterologous animal cells” means that animal cells that are heterologous to the cells are not used as conditions for culturing IPE cells or RPE cells. Specifically, when human cells are used as IP E cells or RPE cells, the conditions are such that cells of animal species other than humans, such as mice and rats, do not exist (coexist) in the culture medium. By culturing under such conditions, there is no possibility that components derived from different species (including heterologous cells themselves) are mixed into the cell components of the transplant material (ie, cultured cell sheet) finally obtained. The primary culture (and subculture as necessary) is also preferably performed in the absence of heterologous animal cells.
[0032] 採取した IPE細胞又は RPE細胞を一旦培養し増殖させた後にコラーゲンゲル薄膜 上に播種するのではなぐ直接コラーゲンゲル薄膜上に播種して培養することにして もよレ、。つまり、コラーゲンゲル薄膜上への播種前に行う培養工程 (IPE細胞又は RPE 細胞の初代培養及び継代培養)を省略してもよい。このようにすれば、培養操作を簡 略化でき、実質的に一段階の培養操作によって細胞層の構築を行える。 [0032] Rather than seeding the collected IPE cells or RPE cells once cultured and grown and then seeding on the collagen gel thin film, it may be seeded directly on the collagen gel thin film and cultured. That is, the culture process (primary culture and subculture of IPE cells or RPE cells) performed before seeding on the collagen gel thin film may be omitted. In this way, the culturing operation can be simplified, and the cell layer can be constructed by a substantially one-step culturing operation.
[0033] (4)培養細胞シートを回収するステップ [0033] (4) Step of collecting cultured cell sheet
以上の方法で培養することにより、コラーゲンゲル薄膜上に IPE由来の細胞(IPE細 胞を使用した場合)又は RPE由来の細胞(RPE細胞を使用した場合)からなる細胞層 が形成された培養細胞シートが得られる。培養容器とコラーゲンゲル薄膜との間の接 着を解除することによって培養細胞シートを回収することができる。例えばピンセット やメスなどを用いてコラーゲンゲル薄膜を剥離する。ここで、支持体付きのコラーゲン ゲル薄膜を用いて培養細胞シートを作製した場合、支持体をピンセットで掴む等して 比較的容易にコラーゲル薄膜を培養容器力 剥離することができる。また、支持体に よって、剥離時におけるコラーゲンゲル薄膜ひレ、ては培養細胞シートの形態を維持 できる。このように、支持体付きのコラーゲンゲル薄膜を使用すれば、状態のよい培 養細胞シートを容易な操作で回収することができる。 By culturing by the above method, a cultured cell in which a cell layer composed of IPE-derived cells (when IPE cells are used) or RPE-derived cells (when RPE cells are used) is formed on a collagen gel thin film. A sheet is obtained. Contact between the culture vessel and the collagen gel film The cultured cell sheet can be collected by releasing the attachment. For example, the collagen gel thin film is peeled off using tweezers or a knife. Here, when a cultured cell sheet is produced using a collagen gel thin film with a support, the collage gel thin film can be peeled off relatively easily in the culture container by grasping the support with tweezers. In addition, the support can maintain the shape of the collagen gel thin film and the cultured cell sheet at the time of peeling. Thus, if a collagen gel thin film with a support is used, a cultured cell sheet in good condition can be collected by an easy operation.
[0034] (培養細胞シートの提供形態) [0034] (Provided form of cultured cell sheet)
本発明の培養細胞シートは、例えば、ガラスやプラスチックの容器に収納され、細 胞培養用培地や UW液等の保存液などに浸漬された状態で提供される。 The cultured cell sheet of the present invention is provided, for example, in a state of being stored in a glass or plastic container and immersed in a cell culture medium or a storage solution such as a UW solution.
[0035] (培養細胞シートの適用症例) [0035] (Applicable cases of cultured cell sheet)
以上の方法で作製された培養細胞シートは RPEの再建が必要な疾患、例えば加齢 黄斑変性、網膜色素変性、糖尿病性網膜症、近視性網脈絡膜萎縮、網膜色素腫瘍 の治療における移植材料 (網膜色素上皮の代替)として用いることができる。 The cultured cell sheet prepared by the above method is a transplant material for the treatment of diseases that require RPE reconstruction, such as age-related macular degeneration, retinitis pigmentosa, diabetic retinopathy, myopic choroidal atrophy, and retinal pigment tumors. It can be used as an alternative to the pigment epithelium.
[0036] (培養細胞シートの移植方法) [0036] (Method of transplanting cultured cell sheet)
培養細胞シートの移植方法の一例として、加齢黄斑変性 (AMD)患者への移植方 法を以下に説明する。 As an example of a method for transplanting cultured cell sheets, the method for transplanting to age-related macular degeneration (AMD) patients is described below.
まず、施術に先行して脈絡膜新生血管(CNV)の存在を確認する。これには通常、 黄斑部を中心とした出血や溶出物などの変化の観察、 fluoresceinangiography (FAG) 又は mdocyamne green angiography (Iし Gノ力木 lj用 2·れ d。 First, the presence of choroidal neovascularization (CNV) is confirmed prior to treatment. This is usually done by observing changes in bleeding and eluate around the macula, fluoresceinangiography (FAG) or mdocyamne green angiography (for Ij-G noriki lj 2 · d.
3ポートを作製し硝子体カッターで硝子体を切除後、術前に走查レーザー検眼鏡(S LO)検査で確認しておいた CNVの近くで、かつ固視点をさけた部位の網膜に弱いジ ァテルミ一凝固後、小穴を作製し CNVを鑷子で把持して摘出する。 CNV摘出後、網 膜下腔を細胞移植針などで洗浄し、浅い網膜剥離の状態を形成する。このようにして 形成した空間に培養細胞シートを移植する。 3 ports are prepared and the vitreous body is excised with a vitreous cutter, and is weak against the retina near the CNV that has been confirmed by a scanning laser ophthalmoscope (S LO) examination before surgery After solidification of diathermy, make a small hole and grasp CNV with an insulator to remove it. After excision of CNV, the subretinal space is washed with a cell transplant needle to form a shallow retinal detachment state. The cultured cell sheet is transplanted into the space thus formed.
実施例 Example
[0037] 1.ガラス化されたコラーゲンゲル薄膜の調製 [0037] 1. Preparation of vitrified collagen gel thin film
国際公開第 2005/014774号パンフレットに記載の方法に従って調製された、厚 さ約 20 μ mのガラス化されたコラーゲンゲル薄膜を、旭テクノグラス株式会社 (千葉、 日本)より入手した。尚、当該コラーゲンゲル薄膜の調製方法の概要を以下に記載す る。 Thickness prepared according to the method described in WO 2005/014774 pamphlet A vitrified collagen gel thin film having a thickness of about 20 μm was obtained from Asahi Techno Glass Co., Ltd. (Chiba, Japan). The outline of the method for preparing the collagen gel thin film is described below.
まず、図 1に示すような円形の支持体をナイロンメンブレン (Amersham#RPN1782B) を切り抜いて作製し、滅菌処理後、疎水性ポリスチレン製 24ゥヱルプレートに入れた。 氷上で冷却した滅菌コニカルチューブに細胞培養液 0.5%1型コラーゲン水溶液 (ゥシ I型コラーゲン、新田ゼラチン社製)をカ卩え、均一に混和した。コラーゲン混合液を先 の支持体を入れた 24ゥエルプレートに入れた後、 5%CO /95%空気存在下の 37°Cの 保湿インキュベーターで 2時間維持してゲル化した。この終濃度 0.25%コラーゲンゲル を、 10°C、 40%湿度の条件下のクリーンベンチ内でふたをはずした状態で無菌的に 2 日間完全に乾燥することでガラス化させた。これに 3mlの PBSを加えることで、ガラス化 したコラーゲンゲル乾燥体を再水和した。さらに数回 3mlの PBSでリンスした。さらにこ のコラーゲンゲル薄膜を、 10°C、 40%湿度の条件下のクリーンベンチ内でふたをは ずした状態で無菌的に 2日間完全に乾燥させた。その後、室温で無菌的に保管維持 した。以下の実験では、 40日間以上、保管維持したコラーゲンゲル乾燥体を使用し た。尚、 40日間以上保管維持した場合、コラーゲンゲル乾燥体を湿潤状態に戻して 得られるコラーゲンゲル薄膜は非常に高い透明度及び強度を有する(詳しくは国際 公開第 2005Z014774号パンフレットを参照)。また、乾燥状態から湿潤状態に移 行する際、ほとんど膨潤が認められない。 First, a circular support as shown in FIG. 1 was prepared by cutting a nylon membrane (Amersham # RPN1782B), sterilized, and placed in a hydrophobic polystyrene 24-wall plate. A cell culture solution 0.5% type 1 collagen aqueous solution (Ushi type I collagen, Nitta Gelatin Co., Ltd.) was placed in a sterile conical tube cooled on ice and mixed uniformly. The collagen mixture was placed in a 24-well plate containing the above support, and then gelled by maintaining it in a humidified incubator at 37 ° C in the presence of 5% CO / 95% air for 2 hours. This final concentration 0.25% collagen gel was vitrified by aseptically drying for 2 days in a clean bench under conditions of 10 ° C and 40% humidity with the lid removed. By adding 3 ml of PBS to this, the dried vitrified collagen gel was rehydrated. Rinse several times with 3 ml of PBS. Furthermore, this collagen gel thin film was aseptically dried for 2 days in a clean bench under conditions of 10 ° C and 40% humidity with the lid removed. Thereafter, it was kept aseptically stored at room temperature. In the following experiments, a dried collagen gel that had been stored for 40 days or longer was used. In addition, when stored and maintained for 40 days or more, the collagen gel thin film obtained by returning the dried collagen gel to a wet state has very high transparency and strength (for details, see International Publication No. 2005Z014774 pamphlet). In addition, almost no swelling is observed when moving from a dry state to a wet state.
2.動物細胞を用いた培養 IPEシートの作製(1) 2. Cultivation using animal cells Preparation of IPE sheet (1)
以下の手順でブタ IPE細胞を用いた培養 IPEシートを作製した。 A cultured IPE sheet using porcine IPE cells was prepared by the following procedure.
2- 1.組織の採取 2- 1. Tissue collection
食用目的で屠殺されるブタを安楽死せしめた後に死体から眼球を摘出した。眼球 は 10時間以内にペニシリン、ストレプトマイシンが含有された約 20mlの眼内灌流液に 浸漬し、 1時間以内に以下の処理を行った。角膜輪部から約 5mm外側をはさみで切り 角膜を含む前眼組織と網膜を含む後眼組織に分離した。セシを用いて前眼組織力 角膜、水晶体を除き虹彩組織を剥離した。含まれるゼリー状の実質を除き眼内灌流 液で十分に洗浄を行うことにより、虹彩色素組織を得ることができた。以後の処理は 別段の記載がない場合はクリーンベンチ内で無菌操作に気をつけて実施した。 After euthanizing pigs slaughtered for food purposes, the eyeballs were removed from the corpses. The eyeball was immersed in about 20 ml of intraocular perfusate containing penicillin and streptomycin within 10 hours, and the following treatment was performed within 1 hour. The outer part of the cornea was cut about 5 mm with scissors and separated into an anterior ocular tissue containing the cornea and a posterior ocular tissue containing the retina. An eye tissue force was removed using cesi. The iris pigmented tissue could be obtained by thoroughly washing with an intraocular perfusate except for the jelly-like substance contained therein. Subsequent processing is When there was no description, it carried out paying attention to aseptic operation in the clean bench.
[0039] 2- 2. IPE細胞の単離 [0039] 2- 2. Isolation of IPE cells
2- 1.で採取を行った虹彩色素組織を BSS (参天製薬) 6ml入り 60 φディッシュに移 し洗浄を行った後、 lOmM EDTA含有 BSS6ml入り 60 φディッシュに移し、静置したま ま 37°C10分間インキュベートした。ディッシュをインキュベータより出し、 IPE培養溶液( F12培地 (Kohjin bio)450ml, FCS(ICN) 50ml,アンフォテリシン (Wako)1.25mg,ゲンタ マイシン (Gibco)250 z 1, bFGF (プロメガ) 5 μ g)を 2ml加えた後にスクレーパを用いて組 織より上皮細胞を注意深く剥離分離した。虹彩色素上皮細胞は黒色をしており、細 胞が剥離された虹彩組織の領域は薄レ、肌色になる。そのため虹彩組織から黒色の 領域が目視にて確認できなくなるまで細胞の剥離を続けた。細胞剥離虹彩組織を除 去後、溶液をピペットで吸引し 15ml遠心チューブに注入し、ディッシュに IPE培養溶液 を 2ml入れ、再び 15ml遠心チューブに注入しディッシュを洗浄した。洗浄操作をもう一 度行った後に 4°C、 3000卬 mで 2分間遠心を行った。上清を除去後、 IPE培養溶液を 5 ml入れてペレットを再縣濁し、 4°C、 3000rpmで 2分間遠心を行った。上清を除去する ことにより細胞のペレットを回収した。 2- Transfer the iris pigmented tissue collected in 1 to a 60 mm dish containing 6 ml of BSS (Santen Pharmaceutical) and then move to a 60 mm dish containing 6 ml of BSS containing lOmM EDTA and leave it still at 37 ° Incubated for 10 minutes. Remove dish from incubator, IPE culture solution (F12 medium (Kohjin bio) 450 ml, FCS (ICN) 50 ml, amphotericin (Wako) 1.25 mg, gentamicin (Gibco) 250 z 1, bFGF (Promega) 5 μg) 2 ml After the addition, epithelial cells were carefully detached from the tissue using a scraper. The iris pigmented epithelial cells are black, and the area of the iris tissue from which the cells have been detached becomes pale and skin-colored. Therefore, cell detachment was continued until the black area could not be visually confirmed from the iris tissue. After removing the cell detachment iris tissue, the solution was aspirated with a pipette and poured into a 15 ml centrifuge tube, and 2 ml of the IPE culture solution was poured into the dish and again poured into a 15 ml centrifuge tube to wash the dish. After another washing operation, centrifugation was performed at 4 ° C and 3000 mm for 2 minutes. After removing the supernatant, 5 ml of IPE culture solution was added and the pellet was resuspended, followed by centrifugation at 4 ° C and 3000 rpm for 2 minutes. The cell pellet was recovered by removing the supernatant.
[0040] 2- 3. IPE細胞の培養 [0040] 2- 3. Culture of IPE cells
IPE細胞の培養には特に記載がない場合は IPE培養液を用いた。 2— 2.で得られ たペレットの入ったチューブに 4mlの IPE培養液を加えてペレットを縣濁し、全溶液を I 型コラーゲンでコートされた 6ゥエルプレート(IWAKI)に加えた。 1ゥエルに対して 1目艮 分の IPE細胞を加えたこととなる。細胞培養は 5%CO、 37°Cの条件のインキュベータ Unless otherwise stated, IPE medium was used for IPE cell culture. 2-4 To the tube containing the pellet obtained in 2 above, 4 ml of IPE medium was added to suspend the pellet, and the whole solution was added to a 6-well plate (IWAKI) coated with type I collagen. One extra IPE cell is added to one well. Cell culture is incubator with 5% CO and 37 ° C
2 2
内で行った。培養後培地交換は行わず、プレートは静置したままにしておいた。この 時期は IPE細胞がプレートに接着をする時期であり、毎日細胞の観察を行った。細胞 がプレートに接着するまでは大体 7日〜10日ほど必要である。その後は 3日おきに IPE 培養液の交換を行った。培地交換は以下の手順により行う。まず lmlピペットを用いて IPE培養液を除去し、 PBSを lmlカ卩ぇプレートを軽く揺らした後に PBSを除去し洗浄を 行った。 IPE細胞を培養する際には培地に黒色の顆粒が見られる。この顆粒は洗浄 操作によって除去される力 回収される PBSから顆粒が観察されなくなるまで PBS洗浄 の操作を繰り返す。通常、洗浄操作は 1度目の培地交換の際には 5回、次回以降の 培地交換の際には 2回行った。その後に IPE培養液を lmlカ卩ぇインキュベータに戻し て培養を継続した。細胞は培養開始 2週後にコンフルェントになり、細胞数は約 5〜7 X 105細胞/ゥエルに達した。 Went in. The medium was not changed after the culture, and the plate was left to stand. This is the period when IPE cells adhere to the plate, and the cells were observed daily. It takes about 7-10 days for the cells to adhere to the plate. Thereafter, the IPE medium was changed every 3 days. The medium is exchanged according to the following procedure. First, the IPE culture solution was removed using an lml pipette, and the PBS was removed by washing the lml cache plate, and then washed. When culturing IPE cells, black granules are seen in the medium. This granule is removed by the washing operation. The PBS washing operation is repeated until no granules are observed in the collected PBS. Normally, the washing operation is performed 5 times at the first medium change, The medium was changed twice. Thereafter, the IPE culture solution was returned to the lml cache incubator and the culture was continued. The cells became confluent after 2 weeks of culture, and the number of cells reached about 5-7 × 10 5 cells / well.
[0041] 2-4. IPE細胞の継代 [0041] 2-4. Passage of IPE cells
3週間培養を行うことによりコンフルェントに達した細胞のあるゥエルを用いて実験を 行った。 1mlピペットを用いて IPE培養液を除去し 0.05%トリプシン/ EDTA溶液 (Invitrog en)を各ゥエル lmlカ卩え、 37°Cインキュベータ内に静置した。適当な時間が経過した後 にプレートをゆすりながら実体顕微鏡下で観察を行い、ほぼすベての細胞が浮遊す るまで処理を続けた。通常、トリプシンの反応時間は 15分であった。ゥエルに IPE培養 溶液を lml入れピペットを用いて 15ml遠心チューブに注入した。ゥエルに IPE培養溶 液を lml入れ再び 15ml遠心チューブに注入しゥエルの洗浄を行った。洗浄操作をもう 一度行ったあとで 4°C、 3000卬 mで 2分間遠心を行った。上清を除去後、 IPE培養液を 16ml加えてペレットを縣濁し、 I型コラーゲンでコートされた 6ゥヱルプレートに各ゥヱル 4mlずつ加え、 5%CO、 37°Cの条件のインキュベータに移した。細胞がプレートに接 着するまでは静置を行い、通常この期間は 2〜3日であった。細胞が接着をした後は 2- 3.と同様の方法にて 3日に 1度の割合で培地の交換を行った。 Experiments were conducted using wells that had reached confluence by culturing for 3 weeks. The IPE culture solution was removed using a 1 ml pipette, 0.05% trypsin / EDTA solution (Invitrogen) was added to each well and placed in a 37 ° C incubator. After an appropriate period of time, the plate was observed under a stereomicroscope while shaking, and the treatment was continued until almost all cells were floating. Usually, trypsin reaction time was 15 minutes. Into the well, lml of the IPE culture solution was poured into a 15ml centrifuge tube using a pipette. 1 ml of IPE culture solution was put into the well and poured into a 15 ml centrifuge tube again to wash the well. After another washing operation, centrifugation was performed at 4 ° C and 3000 mm for 2 minutes. After removing the supernatant, 16 ml of IPE culture solution was added to suspend the pellet, and 4 ml of each was added to a 6-well plate coated with type I collagen, and transferred to an incubator with 5% CO and 37 ° C. The cells were allowed to stand until they were attached to the plate, and this period was usually 2-3 days. After the cells adhered, the medium was changed once every 3 days in the same manner as in 2-3.
[0042] 2- 5. IPE細胞の保存 [0042] 2- 5. Preservation of IPE cells
2- 3.の方法で 3週間培養を行いコンフルェントに達した細胞の存在するゥヱル( 細胞数は約 5 X 10 )を用いて実験を行った。 2_4.と同様の方法で 15mlチューブに 細胞を回収した後に、バンバンカー(日本ジヱネテイクス)を 5ml入れペレットを再縣濁 し 4°C、 3000rpmで 2分間遠心を行った。上清を除去して細胞のペレットを回収し、バ ンバンカーを 10ml入れペレットを縣濁し、そのうちの lmlを 2mlクライオジヱニックチュ ーブに加え、予め一 80°Cのディープフリーザーに置レ、ておレ、た断熱容器の中に移し 、 _80°Cで凍結を行った。一日後にチューブを液体窒素の容器へと移し、 1週間放 置した。 1週間後にチューブを予め 37°Cに保温した高温槽に移し、速やかに融解を 行った。チューブ内の溶液を 15mlチューブに移し、 IPE培養液を 4ml加え 4°C、 3000卬 mで 2分間遠心を行った。上清を除去後、 IPE培養溶液を lml入れ縣濁後、 I型コラー ゲンでコートされた 24ゥエルプレートに細胞を播種し 5%CO、 37°Cの条件のインキュべ ータに移し培養を行った。 1週間後に観察を行ったところ、プレートに接着する細胞が 観察された。 Experiments were carried out using cells that had reached confluence after culturing for 3 weeks by the method described in 2-3. Cells were collected in a 15 ml tube in the same manner as in 2_4. Then, 5 ml of bun bunker (Nippon Gentex) was added and the pellet was resuspended and centrifuged at 4 ° C and 3000 rpm for 2 minutes. Remove the supernatant and collect the cell pellet. Add 10 ml of bunker to suspend the pellet. Add 1 ml of the bunker to a 2 ml cryogenic tube and place it in a deep freezer at 80 ° C in advance. Then, it was transferred into an insulated container and frozen at _80 ° C. One day later, the tube was transferred to a liquid nitrogen container and left for one week. One week later, the tube was transferred to a high-temperature bath preliminarily kept at 37 ° C and thawed immediately. The solution in the tube was transferred to a 15 ml tube, 4 ml of IPE medium was added, and centrifuged at 4 ° C and 3000 mm for 2 minutes. After removing the supernatant, add 1 ml of IPE culture solution, suspend, and inoculate the cells on a 24-well plate coated with type I collagen and incubate under conditions of 5% CO and 37 ° C. The culture was carried out. Observation was performed one week later, and cells adhering to the plate were observed.
[0043] 2-6.細胞層の構築 [0043] 2-6. Construction of cell layer
2- 4.により 5 X 104個の IPE細胞が含まれるペレットを作製し、 IPE培養液を 2ml加え て縣濁し、細胞懸濁液とした。一方、 1.で調製した、ゥシ I型コラーゲンを原料とする 厚さ 20 μ mのコラーゲンゲル乾燥体が付着した 24ゥヱルプレートに IPE培養液を入れ て 37°Cで 15分間インキュベートし、コラーゲンゲル乾燥体の再水和処理を行った。そ の結果得られた湿潤状態のコラーゲンゲル薄膜 (約 20 μ m厚)の上に上記細胞縣濁 液を lml添加した後、 5%CO、 37°Cの条件のインキュベータにプレートを移し、培養し た。培養後は 2— 3.と同様の方法を用いて 3日おきに IPE培養液の交換を行った。培 養開始後約 2〜3日後に細胞はコラーゲンゲル薄膜に接着し、約 2週後にコンフルェ ントに達した(図 2)。 A pellet containing 5 X 10 4 IPE cells was prepared according to 2-4, and 2 ml of IPE culture solution was added and suspended to obtain a cell suspension. On the other hand, the IPE culture solution was placed in a 24-well plate prepared in step 1 to which a dry collagen gel with a thickness of 20 μm was attached, and incubated at 37 ° C for 15 minutes. The dried body was rehydrated. After adding 1 ml of the above cell suspension onto the wet collagen gel thin film (about 20 μm thick) obtained as a result, the plate was transferred to an incubator with 5% CO and 37 ° C, and cultured. did. After culturing, the IPE medium was changed every 3 days using the same method as in 2-3. About 2 to 3 days after the start of culture, the cells adhered to the collagen gel thin film and reached confluence about 2 weeks later (Fig. 2).
[0044] 3.動物細胞を用いた培養 RPEシートの作製(1) [0044] 3. Cultivation using animal cells Production of RPE sheet (1)
以下の手順でブタ RPE細胞を用いた培養 RPEシートを作製した。 A cultured RPE sheet using porcine RPE cells was prepared by the following procedure.
3 - 1.組織の採取 3-1. Tissue collection
食用目的で屠殺されるブタを安楽死せしめた後に死体から眼球を摘出した。眼球 は 10時間以内にペニシリン,ストレプトマイシンが含有された約 20mlの眼内灌流液に 浸漬し、 1時間以内に以下の処理を行った。角膜輪部から約 5mm外側をはさみで切り 角膜を含む前眼組織と網膜を含む後眼組織に分離した。セシを用いて後眼組織力 硝子体と網膜を除去し、次に強膜力 網膜色素膜を剥離し、強膜側に存在する脈絡 膜を剥離することにより組織を得た。眼内灌流液で十分に洗浄を行うことにより、網膜 色素組織を得ることができた。以後の処理は別段の記載がない場合はクリーンベン チ内で無菌操作に気をつけて実施した。 After euthanizing pigs slaughtered for food purposes, the eyeballs were removed from the corpses. The eyeball was immersed in about 20 ml of intraocular perfusate containing penicillin and streptomycin within 10 hours, and the following treatment was performed within 1 hour. The outer part of the cornea was cut about 5 mm with scissors and separated into anterior ocular tissue containing the cornea and posterior ocular tissue containing the retina. Tissue strength was obtained by removing the vitreous body and retina using cesi, and then removing the scleral retinal pigment membrane and the choroid present on the sclera side. Retinal pigment tissue could be obtained by thorough washing with intraocular perfusate. Subsequent processing was performed with care in aseptic operation in a clean bench unless otherwise stated.
[0045] 3 - 2. RPE細胞の単離 [0045] 3-2. Isolation of RPE cells
3 - 1.で採取を行った網膜色素組織を BSS (参天製薬) 6ml入り 60 φディッシュに移 し洗浄を行った後、 lOmM EDTA含有 BSS6ml入り 60 φディッシュに移し、静置したま ま 37°C10分間インキュベートした。ディッシュをインキュベータより出し、 RPE培養溶液 (DMEM培地 (Kohjin bio)450ml, FCS(ICN) 50ml,アンフォテリシン (Wako)1.25mg,ゲ ンタマイシン (Gibco)250 μ 1)を 2ml加えた後にスクレーバを用いて組織より上皮細胞を 注意深く剥離分離した。網膜色素上皮細胞は黒色をしており、細胞が剥離された網 膜色素組織の領域は白色になる。そのため網膜色素組織から黒色の領域が目視に て確認できなくなるまで細胞の剥離を続けた。細胞剥離網膜色素組織を除去後、溶 液をピペットで吸引し 15ml遠心チューブに注入し、ディッシュに RPE培養溶液を 2ml入 れ再び 15ml遠心チューブに注入しディッシュを洗浄した。洗浄操作をもう一度行った あとで 4°C、 3000卬 mで 2分間遠心を行った。上清を除去後、 0.05%トリプシン/ EDTA溶 液を lml加えて再縣濁を行レ、、 37°Cインキュベータ内で 2分間放置した。 2mlの RPE培 養液をカ卩ぇ 3000卬 mで 2分間遠心を行った。上清を除去後、 RPE培養液を 5ml入れて ペレットを再縣濁し 4°C、 3000rpmで 2分間遠心を行った。上清を除去することにより細 胞のペレットを回収した。 Transfer the retinal pigment tissue collected in 3-1 to a 60 mm dish containing 6 ml of BSS (Santen Pharmaceutical) and then move to a 60 mm dish containing 6 ml of BSS containing lOmM EDTA and leave it at 37 ° Incubated for 10 minutes. The dish is removed from the incubator and RPE culture solution (DMEM medium (Kohjin bio) 450 ml, FCS (ICN) 50 ml, amphotericin (Wako) 1.25 mg, After adding 2 ml of ntamycin (Gibco) 250 μl), epithelial cells were carefully detached from the tissue using a scraper. The retinal pigment epithelial cells are black, and the area of the retina pigment tissue from which the cells have been detached becomes white. Therefore, cell detachment was continued until the black area from the retinal pigment tissue could not be visually confirmed. After removing the cell detachment retinal pigment tissue, the solution was aspirated with a pipette and poured into a 15 ml centrifuge tube, and 2 ml of RPE culture solution was poured into the dish and again poured into a 15 ml centrifuge tube to wash the dish. After another washing operation, centrifugation was performed at 4 ° C and 3000 mm for 2 minutes. After removing the supernatant, 1 ml of 0.05% trypsin / EDTA solution was added and re-suspended, and left in a 37 ° C incubator for 2 minutes. Centrifugation of 2 ml of RPE medium at 3000 卬 m for 2 minutes was performed. After removing the supernatant, 5 ml of RPE medium was added and the pellet was resuspended and centrifuged at 4 ° C and 3000 rpm for 2 minutes. The cell pellet was recovered by removing the supernatant.
[0046] 3 - 3. RPE細胞の培養 [0046] 3-3. Culture of RPE cells
RPE細胞の培養には特に記載がない場合は RPE培養液を用いた。 3- 2.で得られ たペレットの入ったチューブに 4mlの RPE培養液を加えてペレットを縣濁し、全溶液を I 型コラーゲンでコートされた 6ゥエルプレート(IWAKI)に加えた。 1ゥエルに対して 1眼 分の RPE細胞をカロえたこととなる。細胞培養は 5%CO、 37°Cの条件のインキュベータ 内で行った。培養後培地交換は行わず、プレートは静置したままにしておいた。この 時期は RPE細胞がプレートに接着をする時期であり、毎日細胞の観察を行った。細 胞がプレートに接着するまでは大体 7日〜10日ほど必要である。その後は 3日おきに RPE培養液の交換を行った。培地交換は 2— 3.と同様の手順により行った。細胞は 培養開始 3週後にコンフルェントになり、細胞数は約 3〜5 X 105細胞/ゥエルに達した RPE medium was used for RPE cell culture unless otherwise stated. 3- In the tube containing the pellet obtained in 2 above, 4 ml of RPE medium was added to suspend the pellet, and the entire solution was added to a 6-well plate (IWAKI) coated with type I collagen. This means that one eye has RPE cells per eye. Cell culture was performed in an incubator with 5% CO and 37 ° C. The medium was not changed after the culture, and the plate was left to stand. This was the time when RPE cells adhered to the plate, and the cells were observed daily. It takes about 7-10 days for the cells to adhere to the plate. Thereafter, the RPE medium was changed every 3 days. The medium was exchanged by the same procedure as 2-3. Cells became confluent after 3 weeks of culture and the cell count reached approximately 3-5 x 10 5 cells / well.
[0047] 3 -4. RPE細胞の継代 [0047] 3-4. Passage of RPE cells
4週間培養を行うことによりコンフルェントに達した細胞のあるゥエルを用いて実験を 行った。 2_4.と同様の方法を用いて細胞の継代を行った。 Experiments were carried out using wells with cells that reached confluence by culturing for 4 weeks. Cells were passaged using the same method as in 2-4.
[0048] 3 - 5. RPE細胞の保存 [0048] 3-5. Preservation of RPE cells
RPE細胞の保存は 2_ 5.と同様の方法により行った。凍結保存 1週間後に RPE培養 溶中で培養を試みたところ、培養開始 1週間後にプレートに接着する細胞が観察され た。 RPE cells were preserved in the same manner as 2-5. Cryopreservation One week after RPE culture Attempting to cultivate in lysis, cells observed to adhere to the plate one week after the start of culture. It was.
[0049] 3 -6.細胞層の構築 [0049] 3 -6. Construction of cell layer
2- 6.と同様の方法により培養 RPEシートを作製した。シート作製開始後約 2〜3日 後に細胞はコラーゲンシートに接着し、約 3週後にコンフルェントに達した(図 3)。 A cultured RPE sheet was prepared in the same manner as in 2- 6. About 2 to 3 days after the start of sheet preparation, the cells adhered to the collagen sheet and reached confluence after about 3 weeks (Fig. 3).
[0050] 4.細胞シートの評価 [0050] 4. Cell sheet evaluation
(a)貪食能の有無(1) (a) Presence or absence of phagocytic ability (1)
培養 IPEシートの貪食能について、ラテックスビーズを用いて試験した。試験には、 2-6.で得られた培養 IPEシートを用いた。まず、 IPEシートが浸漬した IPE培養液中 に平均径 1 μ mのノンコートラテックスビーズ (ポリサイエンス)を 1.0 X 109個投入した。ビ ーズは 1.0 X 109個/ lml/1シート加えたことになる。 37°Cのインキュベータに培養 IPEシ ート含有 24ゥエルプレートを入れて静置した。 6時間経過後にラテックスビーズ含有 IP E培養液を除去した。 PBSを lmlカ卩えてプレートを揺らした後、 PBSを除去することで洗 浄を行った。この洗浄操作は除去した PBS中にラテックスビーズが観察されなくなるま で行い、通常 5回の操作を行った。洗浄操作を実施することにより細胞内に取り込ま れなかった遊離のビーズが培養液から除去される。洗浄操作終了後に PBSを除去し 、ゥエルに 100%アセトンを lml加え 15分静置した。この操作により細胞は固定される。 アセトンを除去し、ゥエルに PBSを lml加え洗浄を行った。洗浄操作は 2回行った。セ シを用いて培養 IPEシートをゥエルから丁寧に剥がし、細胞面が上になるように培養 IP Eシートをスライドガラス上に置いた。培養 IPEシートにマウンティングメディウム (Vector )を 30 μ 1加え、カバーガラスをのせてシールした後、顕微鏡下で観察した。細胞内に ビーズが取り込まれた場合は小さな顆粒が観察されるため、ビーズを取り込ませなか つた培養 ΙΡΕシートと比べて顆粒の有無を観察すれば貪食能を評価できる。結果、ビ ーズを加えた培養 ΙΡΕシートでのみ顆粒が観察され、培養 ΙΡΕシートが貪食能を備え てレ、ることを確認できた(図 4)。 The phagocytic ability of the cultured IPE sheet was tested using latex beads. In the test, the cultured IPE sheet obtained in 2-6. Was used. First, 1.0 × 10 9 uncoated latex beads (polyscience) having an average diameter of 1 μm were placed in an IPE culture solution in which an IPE sheet was immersed. The bead is 1.0 X 10 9 pieces / lml / 1 sheet. A 24-well plate containing a cultured IPE sheet was placed in a 37 ° C incubator and allowed to stand. After 6 hours, the latex bead-containing IPE medium was removed. After adding 1 ml of PBS and shaking the plate, washing was performed by removing PBS. This washing operation was performed until latex beads were no longer observed in the removed PBS, and was usually performed five times. By carrying out the washing operation, free beads that have not been taken up into the cells are removed from the culture medium. After completion of the washing operation, PBS was removed, lml of 100% acetone was added to the well, and the mixture was allowed to stand for 15 minutes. By this operation, the cells are fixed. Acetone was removed, and the well was washed by adding 1 ml of PBS. The washing operation was performed twice. The culture IPE sheet was carefully peeled from the well using cesi, and the culture IPE sheet was placed on a slide glass so that the cell surface was up. 30 μl of mounting medium (Vector) was added to the cultured IPE sheet, sealed with a cover glass, and then observed under a microscope. When beads are taken up into cells, small granules are observed, so that the phagocytic ability can be evaluated by observing the presence or absence of granules compared to the cultured koji sheet without taking up beads. As a result, it was confirmed that granules were observed only in the cultured koji sheet to which beads were added, and that the cultured koji sheet had phagocytic ability (Fig. 4).
3 - 6.で得られた培養 RPEシートについても同様の手順で貪食能を評価したところ 、ビーズを加えた培養 RPEシートでのみ顆粒が観察され、貪食能を確認できた(図 5) The phagocytic ability of the cultured RPE sheet obtained in 3-6 was also evaluated using the same procedure. Granules were observed only in the cultured RPE sheet with beads added, confirming the phagocytic ability (Fig. 5).
[0051] (b)貪食能の有無(2) 培養 IPEシートが視神経外節に対する貪食能を有するか否かを検証した。まず、ブ タの眼球を用いて視神経外節を得た。眼球は、(株)池田食品において食用に屠殺 されるブタの組織を使用した。ブタ眼球の角膜輪部外 5mmの部位を円形に切り、眼 球を前眼部と後眼部に分離した。この後眼部をはさみで二つに切断し、セシを用い て硝子体を除去し、網膜を得た。 BSSで十分に洗浄を行った後、 BSS6mlを入れた 60 Φディッシュに移してスクレーパを用いて脈絡膜側の組織をこすった。網膜組織を除 去後に 4°C、 6000卬 mで 3分間遠心を行い上清を除去することによりペレットを得た。こ のペレットには主に視神経外節が含まれる。ペレットに 100mM NaCl含有 pH8.0 PBS 500 μ 1を加えて縣濁し、 100 μ 1の無水ジメチルホルムアミドに溶解した lmgの蛍光色 素 SNAEFLスクシンイミジノレエステルをカ卩えた。常温暗所で 30分静置を行うことによ り、蛍光ラベルを導入した。 6000卬 mで 3分遠心を行い上清を除去した後、 PBSを lml 加えて縣濁した後に遠心を行い、洗浄操作を行った。洗浄操作を 3回行った後、 200 μ ΐの PBSに再縣濁した。 [0051] (b) Presence of phagocytic ability (2) It was verified whether or not the cultured IPE sheet has phagocytic ability to the optic nerve outer segment. First, an outer optic nerve segment was obtained using a butterfly eyeball. The eyeballs used were porcine tissues slaughtered for food in Ikeda Foods Co., Ltd. A portion of the porcine eyeball 5 mm outside the corneal ring was cut into a circle, and the eyeball was separated into the anterior and posterior segments. Thereafter, the eye part was cut into two parts with scissors, and the vitreous body was removed using cesi to obtain a retina. After thorough washing with BSS, it was transferred to a 60 Φ dish containing 6 ml of BSS and the tissue on the choroid side was rubbed with a scraper. After removing the retinal tissue, the pellet was obtained by centrifuging at 4 ° C and 6000 mm for 3 minutes and removing the supernatant. This pellet contains mainly the optic nerve outer segment. The pellet was suspended by adding 500 μl of pH 8.0 PBS containing 100 mM NaCl, and 1 mg of fluorescent dye SNAEFL succinimidino ester dissolved in 100 μl of anhydrous dimethylformamide was collected. Fluorescent labels were introduced by standing at room temperature in a dark place for 30 minutes. After centrifuging at 6000 μm for 3 minutes to remove the supernatant, lml of PBS was added to suspend and centrifuged, followed by washing. After three washing operations, the suspension was resuspended in 200 μΐ PBS.
2 - 6.で得られた培養 ΙΡΕシートの培養液中に上記の操作によりラベルが導入され た視神経外節を 1ゥエルあたり 50 μ ΐ加え、 5%CO、 37°Cの条件で 3時間インキュベート Add the optic nerve outer segment labeled in the above procedure to the culture obtained in 2-6. 50 μΐ per well, and incubate for 3 hours under conditions of 5% CO and 37 ° C.
2 2
した。培地を除去後、 DMEM/F12を lml加えてプレートを揺らした後に DMEM/F12を 除去することで洗浄を行った。この洗浄操作は通常 5回行った。細胞に取り込まれな かった視神経外節は洗浄操作の過程で除去される。細胞シートを蛍光顕微鏡で観 察して細胞への視神経外節の貪食を観察した。洗浄操作後にゥエルに 100%アセトン を lml加え 15分静置した。この操作により細胞は固定される。アセトンを除去し、ゥエル に PBSを lml加え洗浄を行った。洗浄操作は 2回行った。セシを用いて培養 IPEシート をゥヱルから丁寧に剥がし、細胞面が上になるように培養 IPEシートをスライドガラス上 に置いた。シートにマウンティングメディウム (Vector)を 30 μ ΐカ卩え、カバーガラスをの せてシールした後、蛍光顕微鏡下で観察を行った。細胞内に視神経外節が取り込ま れた場合は蛍光が観察されるため、視神経外節を加えなかった ΙΡΕシートと比較して 蛍光の有無を観察すれば貪食能を評価できる。結果、視神経外節を加えた培養 ΙΡΕ シートでのみ蛍光が観察され、培養 ΙΡΕシートが貪食能を備えていることを確認でき 3 -6.で得られた培養 RPEシートについても同様の手順で貪食能を評価したところ 、神経外節をカ卩えた培養 RPEシートでのみ蛍光が観察され、貪食能を確認できた。 did. After removing the medium, lml of DMEM / F12 was added and the plate was shaken, and then washing was performed by removing DMEM / F12. This washing operation was usually performed 5 times. The optic nerve segment that was not taken up by the cells is removed during the washing process. The cell sheet was observed with a fluorescence microscope to observe phagocytosis of the optic nerve outer segment to the cells. After washing, lml of 100% acetone was added to the well and left for 15 minutes. By this operation, the cells are fixed. Acetone was removed, and 1 ml of PBS was added to the well for washing. The washing operation was performed twice. The culture IPE sheet was carefully peeled off from the tool using sushi, and the culture IPE sheet was placed on a slide glass so that the cell surface was up. 30 μL of mounting medium (Vector) was placed on the sheet, sealed with a cover glass, and then observed under a fluorescence microscope. Since fluorescence is observed when the optic nerve outer segment is taken up into the cell, phagocytic ability can be evaluated by observing the presence or absence of fluorescence in comparison with an acupuncture sheet without optic nerve outer segment added. As a result, fluorescence was observed only in the cultured ΙΡΕ sheet with the optic nerve outer segment added, confirming that the cultured ΙΡΕ sheet has phagocytic ability. The phagocytic ability of the cultured RPE sheet obtained in 3-6. Was also evaluated in the same manner. As a result, fluorescence was observed only in the cultured RPE sheet with the nerve outer segment covered, and the phagocytic ability was confirmed.
[0052] 5.動物細胞を用いた培養 IPEシートの作製(2) [0052] 5. Cultivation using animal cells Production of IPE sheet (2)
サル IPE細胞を用いて培養 IPEシートの作製を試みた。操作手順は、ブタ IPE細胞を 用いた場合と同様とした。サル IPE細胞はブタ IPE細胞と比べて細胞増殖がやや遅く 、培養時にコンフルェントに達するまで 2〜3週を要したという相違点があったものの、 ブタ IPE細胞を用いた場合と同等の培養 IPEシートを作製することができた。この結果 より、上記の作製方法が、ブタ IPE細胞を用いた場合にのみ有効なものではなぐ汎 用性に優れていることが確認された。 Preparation of cultured IPE sheets using monkey IPE cells was attempted. The operating procedure was the same as when porcine IPE cells were used. Monkey IPE cells grew slightly slower than porcine IPE cells, and took 2-3 weeks to reach confluency during culture, but cultured IPE sheets equivalent to those using porcine IPE cells Was able to be produced. From this result, it was confirmed that the above-described production method was excellent in versatility that was not effective only when porcine IPE cells were used.
[0053] 6.動物細胞を用いた培養 RPEシートの作製(2) [0053] 6. Cultivation using animal cells Production of RPE sheet (2)
サル RPE細胞を用いて培養 REPシートの作製を試みた。操作手順は、ブタ IPE細胞 を用いた場合と同様とした。サル RPE細胞はブタ RPE細胞と比べて細胞増殖がやや 遅ぐ培養時にコンフルェントに達するまで 3〜4週を要したという相違点があったもの の、ブタ RPE細胞を用いた場合同等の培養 RPEシートを作製することができた。この 結果より、上記の作製方法が、ブタ RPE細胞を用いた場合にのみ有効なものではなく 、汎用性に優れていることが確認された。 An attempt was made to prepare cultured REP sheets using monkey RPE cells. The operating procedure was the same as when porcine IPE cells were used. Although monkey RPE cells differed from porcine RPE cells in that the cell growth was slightly slower, it took 3 to 4 weeks to reach confluence, but when cultured with porcine RPE cells, the same culture RPE sheet was used. Was able to be produced. From this result, it was confirmed that the above production method is not effective only when porcine RPE cells are used, and is excellent in versatility.
[0054] 7.ヒト自家細胞を用いた培養 IPEシートの作製 [0054] 7. Preparation of cultured IPE sheet using human autologous cells
7- 1.組織の採取 7- 1. Tissue collection
インフォームドコンセントが得られた患者から局所麻酔下に角膜上輪部より切開を 行い、外科的に上部虹彩切除術を施行し虹彩色素組織を約 2 X 2mm切除し組織を 摘出する。摘出組織は約 2mlの眼内灌流液に浸漬を行レ、、 1時間以内に次の処理を 行う。以後の処理は別段の記載がない場合はクリーンベンチ内で無菌操作に気をつ けて実施する。 An incision is made from the patient's informed consent through the upper corneal region under local anesthesia, and the upper iris is removed surgically, and the iris pigmented tissue is removed approximately 2 X 2 mm and the tissue is removed. The excised tissue should be immersed in about 2 ml of intraocular perfusate and the following treatment should be performed within 1 hour. If there is no other description, perform the subsequent processing with care for aseptic operation in a clean bench.
[0055] 7- 2. IPE細胞の単離 [0055] 7- 2. Isolation of IPE cells
7- 1.で採取を行った虹彩色素組織を BSS (参天製薬) 6ml入り 60 φディッシュに移 し洗浄を行った後、 lOmM EDTA含有 BSS6ml入り 60 φディッシュに移し、静置したま ま 37°C10分間インキュベートする。ディッシュをインキュベータより出し、 IPE培養溶液 (F12培地 (Kohjin bio)450ml, FCS(ICN) 50ml,アンフォテリシン (Wako)1.25mg,ゲンタ マイシン (Gibco)250 z 1, bFGF (プロメガ) 5 μ g)を 2ml加えた後にスクレーパを用いて組 織より上皮細胞を注意深く剥離分離する。虹彩色素上皮細胞は黒色をしており、細 胞が剥離された虹彩組織の領域は薄い肌色になる。そのため虹彩組織から黒色の 領域が目視にて確認できなくなるまで細胞の剥離を続ける。細胞剥離虹彩組織を除 去後、溶液をピペットで吸引し 15ml遠心チューブに注入し、ディッシュに IPE培養溶液 を 2ml入れ再び 15ml遠心チューブに注入しディッシュを洗浄する。洗浄操作をもう一 度行った後、 4°C、 3000rpmで 2分間遠心を行う。上清を除去後、 IPE培養溶液を 5ml 入れてペレットを再縣濁し 4°C、 3000rpmで 2分間遠心を行う。上清を除去することによ り細胞のペレットを回収する。 7- Move the iris pigment tissue collected in 1. to a 60 mm dish containing 6 ml of BSS (Santen Pharmaceutical), and then move to a 60 mm dish containing 6 ml of BSS containing lOmM EDTA. Incubate for 10 minutes. Take out the dish from the incubator, IPE culture solution (F12 medium (Kohjin bio) 450 ml, FCS (ICN) 50 ml, amphotericin (Wako) 1.25 mg, Genta 2 ml of mycin (Gibco) 250 z 1, bFGF (Promega) 5 μg) is added, and then the epithelial cells are carefully detached from the tissue using a scraper. The iris pigment epithelial cells are black, and the area of the iris tissue from which the cells have been detached becomes a light skin color. Therefore, detachment of the cells is continued until the black area cannot be visually confirmed from the iris tissue. After removing the cell detachment iris tissue, aspirate the solution with a pipette and inject it into a 15 ml centrifuge tube. Add 2 ml of IPE culture solution to the dish, and again inject into the 15 ml centrifuge tube to wash the dish. After another washing, centrifuge at 4 ° C and 3000rpm for 2 minutes. After removing the supernatant, add 5 ml of IPE culture solution, resuspend the pellet, and centrifuge at 4 ° C and 3000 rpm for 2 minutes. Collect the cell pellet by removing the supernatant.
[0056] 7- 3. IPE細胞の培養 [0056] 7- 3. Culture of IPE cells
IPE細胞の培養には特に記載がない場合は IPE培養液を用いる。 7— 2.で得られた ペレットの入ったチューブに lmlの IPE培養液を加えてペレットを縣濁し、全溶液を I型 コラーゲンでコートされた 24ゥエルプレート(IWAKI)に加える。 1ゥヱルに対して 1組織 分の IPE細胞を加えることとなる。細胞培養は 5%CO、 37°Cの条件のインキュベータ内 で行う。培養後培地交換は行わず、プレートは静置したままにしておく。この時期は IP E細胞がプレートに接着をする時期であり、毎日細胞の観察を行う。細胞がプレート に接着するまでは大体 7日〜 10日ほど必要である。その後は 3日おきに IPE培養液の 交換を行う。培地交換は以下の手順により行う。まず lmlピペットを用いて IPE培養液 を除去し、 PBSを lml加えプレートを軽く揺らした後に PBSを除去し洗浄を行う。 IPE細 胞を培養する際には培地に黒色の顆粒が見られる。この顆粒は洗浄操作によって除 去される力 回収される PBSから顆粒が観察されなくなるまで PBS洗浄の操作を繰り返 す。通常、洗浄操作は 1度目の培地交換の際には 5回、次回以降の培地交換の際に は 2回行う。その後に IPE培養液を lmlカ卩えてインキュベータに戻し、培養を継続する。 細胞は培養開始から 2〜3週間程度でコンフルェントになる。 Use IPE medium unless otherwise specified for IPE cell culture. 7— Add lml of IPE medium to the tube containing the pellet obtained in step 2 to suspend the pellet, and add the whole solution to a 24 well plate (IWAKI) coated with type I collagen. One tissue worth of IPE cells is added to one tool. Cell culture is performed in an incubator with 5% CO and 37 ° C. After the culture, the medium is not changed, and the plate is left still. This is the period when IP E cells adhere to the plate, and the cells are observed daily. It takes about 7-10 days for the cells to adhere to the plate. After that, change the IPE medium every 3 days. The medium is exchanged according to the following procedure. First, remove the IPE broth using an lml pipette, add lml of PBS, shake the plate gently, remove the PBS, and wash. When culturing IPE cells, black granules are seen in the medium. The force that this granule is removed by the washing operation Repeat the PBS washing operation until no granules are observed from the recovered PBS. Usually, the washing operation is performed 5 times for the first medium change and twice for the subsequent medium change. Then, add lml of IPE medium and return to the incubator to continue the culture. Cells become confluent about 2-3 weeks after the start of culture.
[0057] 7-4. IPE細胞の継代 [0057] 7-4. Passage of IPE cells
24ゥエルプレート内でコンフルェントに達した細胞のあるゥエルを用いて実験を行う 。 lmlピペットを用いて IPE培養液を除去し 0.05%トリプシン/ EDTA溶液 (Invitrogen)を 各ゥエル lml加え、 37°Cインキュベータ内に静置する。適当な時間が経過した後にプ レートをゆすりながら実体顕微鏡下で観察を行レ、、ほぼすベての細胞が浮遊するま で処理を続ける。通常、トリプシンの反応時間は 15分である。ゥエルに IPE培養溶液を lml入れピペットを用いて 15ml遠心チューブに注入する。ゥエルに IPE培養溶液を lml 入れ再び 15ml遠心チューブに注入しゥエルの洗浄を行う。洗浄操作をもう一度行つ たあとで 4°C、 3000卬 mで 2分間遠心を行う。上清を除去後、 IPE培養液を 4ml加えてぺ レットを縣濁し、 I型コラーゲンでコートされた 24ゥエルプレートに各ゥヱル lmlずつ加え 、 5%CO、 37°Cの条件のインキュベータに移す。細胞がプレートに接着するまでは静 置を行い、通常この期間は 2〜3日程度である。細胞が接着をした後は 7— 3.と同様 の方法にて 3日に 1度の割合で培地の交換を行う。 Experiment with a well with cells that have reached confluence in a 24 well plate. Remove the IPE culture solution using an lml pipette, add 0.05 ml of 0.05% trypsin / EDTA solution (Invitrogen), and leave it in a 37 ° C incubator. After a certain amount of time has passed While observing under a stereomicroscope while shaking the rate, continue the treatment until almost all cells float. Usually, trypsin reaction time is 15 minutes. Add lml of IPE culture solution to the well and inject into a 15ml centrifuge tube using a pipette. Add lml of IPE culture solution to the well and pour it again into a 15ml centrifuge tube to wash the well. Repeat the washing procedure, and then centrifuge at 4 ° C and 3000 mm for 2 minutes. After removing the supernatant, add 4 ml of IPE broth to suspend the pellet, add 1 ml of each well to a 24-well plate coated with type I collagen, and transfer to an incubator with 5% CO at 37 ° C. . The cells are allowed to stand until they adhere to the plate, and this period is usually about 2 to 3 days. After the cells have adhered, the medium is changed once every 3 days in the same way as in 7-3.
[0058] 7- 5. IPE細胞の保存 [0058] 7-5. Preservation of IPE cells
7- 3.の方法で 3週間培養を行いコンフルェントに達した細胞の存在するゥヱルを 用いて実験を行う。 7-4.と同様の方法で 15mlチューブに細胞を回収した後、バン バンカー(日本ジエネテイクス)を 5ml入れペレットを再縣濁し 4°C、 3000卬 mで 2分間遠 心を行う。上清を除去して細胞のペレットを回収し、バンバンカーを lml入れペレットを 縣濁し 2mlクライオジェニックチューブに加え、予め 80°Cのディープフリーザーに置 レ、ておいた断熱容器の中に移し、—80°Cで凍結を行う。一日後にチューブを液体窒 素の容器へと移し、 1週間放置する。 1週間後にチューブを予め 37°Cに保温した高温 槽に移し、速やかに融解を行う。チューブ内の溶液を 15mlチューブに移し、 IPE培養 液を 4mlカ卩ぇ 4°C、 3000rpmで 2分間遠心を行う。上清を除去後、 IPE培養溶液を lml入 れて縣濁後、 I型コラーゲンでコートされた 24ゥヱルプレートに細胞を播種し 5%CO、 3 Incubate for 3 weeks using the method described in 7-3 and then use the cells that have reached confluent cells. Collect cells in a 15 ml tube in the same manner as in 7-4. Then, add 5 ml of bun bunker (Nihon Genenetics), resuspend the pellet, and centrifuge at 4 ° C and 3000 mm for 2 minutes. Remove the supernatant and collect the cell pellet. Add lml of bun bunker to the pellet, add it to the 2ml cryogenic tube, place it in a deep freezer at 80 ° C, and transfer it to the insulated container. Freeze at –80 ° C. After one day, transfer the tube to a liquid nitrogen container and leave it for a week. After one week, transfer the tube to a high-temperature bath pre-incubated at 37 ° C and immediately thaw. Transfer the solution in the tube to a 15 ml tube, and centrifuge the IPE culture solution at 4 ml, 4 ° C, 3000 rpm for 2 minutes. After removing the supernatant, lml of IPE culture solution was added and suspended, and the cells were seeded on a 24-well plate coated with type I collagen, and 5% CO, 3
7°Cの条件のインキュベータに移し培養を行う。 1週間後に観察を行い、プレートに接 着する細胞を観察する。 Transfer to an incubator at 7 ° C and culture. Observe one week later and observe the cells attached to the plate.
[0059] 7-6.細胞層の構築 [0059] 7-6. Construction of cell layer
7-4.により所定の数の IPE細胞が含まれるペレットを作製し、 IPE培養液を 2ml加え て縣濁し、細胞懸濁液とする。一方、 1.で調製した、ゥシ I型コラーゲンを原料とする 厚さ 20 μ mのコラーゲンゲル乾燥体が付着した 24ゥヱルプレートに IPE培養液を入れ て 37°Cで 15分間インキュベートし、コラーゲンゲル乾燥体の再水和処理を行う。その 結果得られた湿潤状態のコラーゲンゲル薄膜 (約 20 μ m厚)の上に上記細胞縣濁液 を lml添加した後、 5%CO、 37°Cの条件のインキュベータにプレートを移し、培養するPrepare a pellet containing the specified number of IPE cells according to 7-4. Add 2 ml of IPE broth and suspend to make a cell suspension. On the other hand, the IPE culture solution was placed in a 24-well plate prepared in step 1 to which a dry collagen gel with a thickness of 20 μm was attached, and incubated at 37 ° C for 15 minutes. Rehydrate the dried body. As a result, the cell suspension is placed on the wet collagen gel thin film (about 20 μm thick). After adding lml, transfer the plate to an incubator with 5% CO and 37 ° C, and incubate
。培養後は 7— 3.と同様の方法を用いて 3日おきに IPE培養液の交換を行う。培養開 始後約 2〜3日後に細胞はコラーゲンゲル薄膜に接着し、 2週間程度の培養でコンフ ルェントに達する。 . After incubation, replace the IPE medium every 3 days using the same method as described in 7-3. About 2 to 3 days after the start of the culture, the cells adhere to the collagen gel thin film and reach confluence after about 2 weeks of culture.
[0060] 8.ヒト自家細胞を用いた培養 RPEシートの作製 [0060] 8. Preparation of cultured RPE sheet using human autologous cells
8 - 1.組織の採取 8-1. Tissue collection
インフォームドコンセントが得られた患者を対象に、局所麻酔下に強膜切開を行う。 硝子体切除術を施行し、黄斑部より十分に離れた周辺部網膜下より健常な RPEを約 2 X 2mm採取を行う。摘出組織は約 2mlの眼内灌流液に浸漬を行レ、、 1時間以内に次 の処理を行う。以後の処理は別段の記載がない場合はクリーンベンチ内で無菌操作 に気をつけて実施する。 A scleral incision is performed under local anesthesia for patients with informed consent. A vitrectomy is performed, and about 2 X 2 mm of healthy RPE is taken from the subretinal area sufficiently far from the macula. The excised tissue should be immersed in about 2 ml of intraocular perfusate, and the following treatment should be performed within 1 hour. If there is no other description, perform the subsequent processing with care for aseptic operation in a clean bench.
[0061] 8 - 2. RPE細胞の単離 [0061] 8-2. Isolation of RPE cells
8 - 1.で採取を行った網膜色素組織を BSS (参天製薬) 6ml入り 60 φディッシュに移 し洗浄を行った後、 10mM EDTA含有 BSS6ml入り 60 φディッシュに移し、静置したま ま 37°C10分間インキュベートする。ディッシュをインキュベータより出し、 RPE培養溶液 (DMEM培地 (Kohjin bio)450ml, FCS(ICN) 50ml,アンフォテリシン (Wako)1.25mg,ゲ ンタマイシン (Gibco)250 μ 1)を 2ml加えた後にスクレーパを用いて組織より上皮細胞を 注意深く剥離分離する。網膜色素上皮細胞は黒色をしており、細胞が剥離された網 膜色素組織の領域は白色になる。そのため網膜色素組織から黒色の領域が目視に て確認できなくなるまで細胞の剥離を続ける。細胞剥離網膜色素組織を除去後、溶 液をピペットで吸引し 15ml遠心チューブに注入し、ディッシュに RPE培養溶液を 2ml入 れ再び 15ml遠心チューブに注入しディッシュを洗浄する。洗浄操作をもう一度行った あとで 4°C、 3000卬 mで 2分間遠心を行う。上清を除去後、 0.05%トリプシン/ EDTA溶液 を lml加えて再縣濁を行レ、、 37°Cインキュベータ内で 2分間放置する。 2mlの RPE培養 液を加え 3000rpmで 2分間遠心を行う。上清を除去後、 RPE培養液を 5ml入れペレット を再縣濁し 4°C、 3000卬 mで 2分間遠心を行う。上清を除去することにより細胞のペレツ トを回収する。 Move the retinal pigment tissue collected in 8-1 to a 60 mm dish containing 6 ml of BSS (Santen Pharmaceutical) and then move to a 60 mm dish containing 6 mM BED containing 6 mM EDTA and leave it at 37 ° Incubate for 10 minutes. Remove the dish from the incubator, add 2 ml of RPE culture solution (DMEM medium (Kohjin bio) 450 ml, FCS (ICN) 50 ml, amphotericin (Wako) 1.25 mg, gentamicin (Gibco) 250 μ1), and then use a scraper. Carefully exfoliate and separate epithelial cells. The retinal pigment epithelial cells are black, and the area of the retina pigment tissue from which the cells have been detached becomes white. Therefore, detachment of the cells is continued until no black area can be visually confirmed from the retinal pigment tissue. After removing the cell detachment retinal pigment tissue, aspirate the solution with a pipette and inject it into a 15 ml centrifuge tube. Add 2 ml of RPE culture solution to the dish and inject again into the 15 ml centrifuge tube to wash the dish. Repeat the washing procedure, and then centrifuge at 4 ° C and 3000 mm for 2 minutes. After removing the supernatant, add 1 ml of 0.05% trypsin / EDTA solution, re-suspend, and leave in a 37 ° C incubator for 2 minutes. Add 2 ml of RPE medium and centrifuge at 3000 rpm for 2 minutes. After removing the supernatant, add 5 ml of RPE medium and resuspend the pellet, and centrifuge at 4 ° C and 3000 µm for 2 minutes. Collect the pellets of the cells by removing the supernatant.
[0062] 8 - 3. RPE細胞の培養 RPE細胞の培養には特に記載がない場合は RPE培養液を用いる。 8- 2.で得られ たペレットの入ったチューブに lmlの RPE培養液を加えてペレットを縣濁し、全溶液を I 型コラーゲンでコートされた 24ゥヱルプレート(IWAKI)に加える。 1ゥヱルに対して 1組 織分の RPE細胞をカロえたこととなる。細胞培養は 5%CO、 37°Cの条件のインキュベー タ内で行う。培養後培地交換は行わず、プレートは静置したままにしておく。この時期 は RPE細胞がプレートに接着をする時期であり、毎日細胞の観察を行う。細胞がプレ ートに接着するまでは大体 7日〜10日ほど必要である。その後は 3日おきに RPE培養 液の交換を行う。培地交換は 7— 3.と同様の手順により行う。細胞は培養開始から 3 〜4週程度でコンフルェントになる。 [0062] 8-3. RPE cell culture Use RPE medium unless otherwise stated for RPE cell culture. 8- Add lml RPE medium to the tube containing the pellet obtained in step 2 to suspend the pellet, and add the whole solution to a 24-well plate (IWAKI) coated with type I collagen. This means that one tissue of RPE cells has been saved per tool. Cell culture is performed in an incubator with 5% CO and 37 ° C. After the culture, the medium is not changed, and the plate is left still. This is the time when RPE cells adhere to the plate, and the cells are observed daily. It takes about 7-10 days for the cells to adhere to the plate. After that, change the RPE medium every 3 days. Replace the medium in the same way as in 7-3. Cells become confluent about 3-4 weeks after the start of culture.
[0063] 8 -4. RPE細胞の継代 [0063] 8 -4. Passage of RPE cells
7-4.と同様の方法で細胞の継代を行う。 Passage cells in the same way as in 7-4.
[0064] 8 - 5. RPE細胞の保存 [0064] 8-5. Preservation of RPE cells
7- 5.と同様の方法で RPE細胞の保存は行う。 7- Store RPE cells in the same way as in 5.
[0065] 8 -6.細胞層の構築 [0065] 8 -6. Construction of cell layer
7-6.と同様の方法で培養 RPEシートを作製する。 Prepare a culture RPE sheet in the same way as in 7-6.
[0066] 9.ヒト他家細胞を用いた培養 IPEシートの作製 [0066] 9. Preparation of cultured IPE sheets using human allogeneic cells
アイバンクから得られる眼球を用いて他家 IPEを採取することができる。死体から全 眼球を摘出後できる限り早期にォプチゾールなどの眼球保存液に入れる。角膜輪部 力 約 5mm外側をはさみで切り角膜を含む前眼組織と網膜を含む後眼組織に分離 する。セシを用いて前眼組織力 角膜、水晶体を除き虹彩組織を剥離する。含まれる ゼリー状の実質を除き BSSで十分に洗浄を行うことにより、虹彩色素組織を得ることが できる。このようにして得られた虹彩色素組織を用いて、 7— 2.〜7_ 6.と同様の方 法で培養 IPEシートを作製する。 Allogeneic IPE can be collected using an eyeball obtained from an eye bank. After removing the whole eyeball from the corpse, place it in an ocular storage solution such as optisol as soon as possible. Corneal limbal force About 5 mm outside is cut with scissors to separate the anterior ocular tissue including the cornea and the posterior ocular tissue including the retina. Anterior tissue force using cesi Remove the iris tissue except the cornea and lens. Iris pigment tissue can be obtained by thoroughly washing with BSS except for the jelly-like substance contained. Using the iris pigment tissue obtained in this way, prepare a cultured IPE sheet in the same manner as in 7-2 to 7_6.
[0067] 10.ヒト他家細胞を用いた培養 RPEシートの作製 [0067] 10. Cultivation using human allogeneic cells Production of RPE sheet
アイバンクから得られる眼球を用いて他家 RPEを採取することができる。死体から全 眼球を摘出後できる限り早期にォプチゾールなどの眼球保存液に入れる。角膜輪部 力 約 5mm外側をはさみで切り角膜を含む前眼組織と網膜を含む後眼組織に分離 する。セシを用いて後眼組織力、ら硝子体と網膜を除去し、次に強膜から網膜色素膜 を剥離し、強膜側に存在する脈絡膜を剥離することにより網膜色素組織を得る。 BSS で十分に洗浄を行うことにより、網膜色素組織を得ることができる。このようにして得ら れた網膜色素組織を用いて、 8 _ 2.〜8_ 6.と同様の方法で培養 RPEシートを作製 する。 Allogeneic RPE can be collected using an eyeball obtained from an eye bank. After removing the whole eyeball from the cadaver, place it in an ophthalmic preservation solution such as optisol as soon as possible. Corneal limbal force About 5 mm outside is cut with scissors to separate the anterior ocular tissue including the cornea and the posterior ocular tissue including the retina. Remove the posterior ocular tissue force from the vitreous and retina using cesi, then retina pigmented membrane from the sclera And the choroid present on the sclera side is peeled to obtain a retinal pigment tissue. Retinal pigment tissue can be obtained by thorough washing with BSS. Using the retinal pigment tissue thus obtained, a cultured RPE sheet is prepared in the same manner as in 8_2 to 8_6.
[0068] 11.一段階培養法による、培養細胞シートの作製 [0068] 11. Preparation of cultured cell sheet by one-step culture method
(a)培養 IPEシート (a) Culture IPE sheet
7- 1.及び 7— 2.に記載した方法によって、単離された IPE細胞を得る。これに培 養液を加えて細胞浮遊液を調製する。 1.に記載の方法で調製したガラス化されたコ ラーゲンゲル薄膜上へ細胞浮遊液を播種し、その後は 7— 6.と同様の操作で培養 を行う。以上のように、採取した IPE細胞をコラーゲンゲル薄膜上で直接培養して培 養 IPEシートを得る。 Obtain isolated IPE cells by the methods described in 7-1. And 7-2. Add the culture solution to this to prepare the cell suspension. Cell suspension is seeded on the vitrified collagen gel thin film prepared by the method described in 1., and then cultured in the same manner as in 7-6. As described above, the collected IPE cells are directly cultured on a collagen gel thin film to obtain a cultured IPE sheet.
(b)培養 RPEシート (b) Culture RPE sheet
8 - 1.及び 8— 2.に記載した方法によって、単離された RPE細胞を得る。これに培 養液を加えて細胞浮遊液を調製する。 1.に記載の方法で調製したガラス化されたコ ラーゲンゲル薄膜上へ細胞浮遊液を播種し、その後は 8— 6.と同様の操作で培養 を行う。以上のように、採取した RPE細胞をコラーゲンゲル薄膜上で直接培養して培 養 RPEシートを得る。 Obtain isolated RPE cells by the methods described in 8-1. and 8-2. Add the culture solution to this to prepare the cell suspension. Cell suspension is seeded on the vitrified collagen gel thin film prepared by the method described in 1., and then cultured in the same manner as in 8-6. As described above, the collected RPE cells are directly cultured on a collagen gel thin film to obtain a cultured RPE sheet.
[0069] 12.培養細胞シートの網膜下への移植 [0069] 12. Transplantation of cultured cell sheet under the retina
培養 IPEシート又は培養 RPEシートの移植は、以下の手順で実施することができる。 まず、 2%メチルセルロースをレシピエント角膜にのせた後、硝子体手術用コンタクトレ ンズを設置し、 11時方向に強膜切開を行う。硝子体切除を行った後、強膜切開創か ら 36G針を挿入し、病巣部位に網膜切開を作製する。網膜切開創から網膜下に眼内 灌流液を少量注入して人工的網膜剥離を作製する。強膜切開創を広げて網膜下に 培養細胞シート(培養 IPEシート又は培養 RPEシート)を揷入する。培養細胞シートを 移植した後、網膜切開創にレーザー光凝固を行い、眼下位を空気あるいは膨張性ガ スで置換する。移植後には空気あるいはガスが吸収されるまで腹臥位をとる。 Transplantation of cultured IPE sheet or cultured RPE sheet can be carried out by the following procedure. First, after placing 2% methylcellulose on the recipient cornea, a contact lens for vitreous surgery is placed and a scleral incision is made at 11 o'clock. After vitrectomy, insert a 36G needle from the scleral incision to make a retinal incision at the lesion site. Artificial retinal detachment is made by injecting a small amount of intraocular perfusate from the retinal incision into the subretinal region. Spread the scleral incision and insert a cultured cell sheet (cultured IPE sheet or cultured RPE sheet) under the retina. After transplanting the cultured cell sheet, laser photocoagulation is performed on the retinal incision, and the lower eye is replaced with air or expandable gas. After transplanting, keep the prone position until air or gas is absorbed.
[0070] 13.培養条件、培養方法の検討 [0070] 13. Examination of culture conditions and culture method
13 - 1. IPE初代培養時のディッシュのコーティング 2- 3.において I型コラーゲンコートディッシュの代わりにプラズマ処理ノンコートデ イツシュ、 IV型コラーゲンディッシュ、ラミニンコートディッシュ、ファイブロネクチンコー トディッシュ、又はマトリゲルコートディッシュを使用して培養した。初代培養開始から 1 週間後に各ディッシュを観察し、接着細胞数を指標として培養に最適な担体の種類 を検討した。結果、 IV型コラーゲンディッシュ又はファイブロネクチンコートディッシュ を使用した条件では、 I型コラーゲンコートディッシュを使用した場合とほぼ同程度の 接着細胞数が認められた。一方、プラズマ処理ノンコートディッシュ又はラミニンコート ディッシュを使用した条件では接着細胞数の若干の減少が認められ、マトリゲルコー トディッシュを使用した条件では細胞増殖が観察されなかった。以上の結果より、 IPE 細胞を初代培養する際のディッシュとしては、表面に I型コラーゲンをコートしたものが 費用、効果の面で最良と思われた。一方、細胞増殖率の点で若干劣るものの、ブラ ズマ処理ノンコートディッシュも実用に耐えることが判明した。 13-1. Dish coating for IPE primary culture In 2-3, the cells were cultured using a plasma-treated non-coated dish, a type IV collagen dish, a laminin coated dish, a fibronectin coated dish, or a matrigel coated dish instead of the type I collagen coated dish. One week after the start of primary culture, each dish was observed, and the optimal carrier type for culture was examined using the number of adherent cells as an index. As a result, under the conditions using type IV collagen dish or fibronectin coated dish, the number of adherent cells was almost the same as when using type I collagen coated dish. On the other hand, a slight decrease in the number of adherent cells was observed under the conditions using the plasma-treated non-coated dish or laminin-coated dish, and no cell proliferation was observed under the conditions using the matrigel-coated dish. Based on the above results, it was considered that the best dish for the primary culture of IPE cells was the coating of type I collagen on the surface in terms of cost and effectiveness. On the other hand, it was found that a plasma-treated non-coated dish was also able to withstand practical use although the cell growth rate was slightly inferior.
[0071] 13 - 2.細胞初代培養時の血清の濃度 [0071] 13-2. Serum concentration during primary cell culture
初代培養時の培養液中の FCS濃度と細胞生存率 (細胞増殖率)との関係を調べた 。 2— 3.及び 3— 3.において、培養液中の FCSの含有濃度を 10%から 5、 3、 1、又は 0 %に下げた条件で培養し、培養 1週間後のディッシュにおいて接着細胞の存否を観察 した。また、接着細胞が存在する場合には、 FCS 10%の条件との間で接着細胞の数 を比較した。結果、 IPE細胞の培養では、 FCS 5%以上の条件で FCS 10%の条件と同 程度の接着細胞数が認められ、 FCS 3%の条件では接着細胞数はやや少なくなり、 F CS 1%以下の条件では接着細胞が観察されなかった。 RPE細胞の培養では、 FCS 3% 以上の条件で FCS 10%の条件と同程度の接着細胞数が認められ、 FCS 1%の条件で はやや少なくなり、 FCS 0%の条件では接着細胞が観察されなかった。以上の結果よ り、初代培養時の培養液中の血清濃度は、 IPE細胞の場合においては少なくとも 3%ま で、 RPE細胞の場合においては少なくとも 1%までは下げることが可能であるといえる。 血清濃度を下げることにより培養時の費用を低減することができ、加えて血清に含ま れる異種タンパク質やウィルスの混入リスクを低減することもできる。 The relationship between FCS concentration in the culture medium during primary culture and cell viability (cell proliferation rate) was examined. In 2−3 and 3−3, culture is performed under the condition that the concentration of FCS in the culture solution is reduced from 10% to 5, 3, 1, or 0%. The existence was observed. When adherent cells were present, the number of adherent cells was compared with the FCS 10% condition. As a result, in the culture of IPE cells, the number of adherent cells was the same as the condition of FCS 10% when FCS was 5% or more, and the number of adherent cells was slightly reduced under the condition of FCS 3%, F CS 1% or less Adherent cells were not observed under the conditions. In RPE cell culture, the number of adherent cells was the same as FCS 10% when FCS was 3% or higher, slightly lower when FCS was 1%, and adherent cells were observed when FCS was 0%. Was not. From the above results, it can be said that the serum concentration in the culture medium during primary culture can be lowered to at least 3% in the case of IPE cells and to at least 1% in the case of RPE cells. By lowering the serum concentration, it is possible to reduce the culture cost, and in addition, it is possible to reduce the risk of contamination with foreign proteins and viruses contained in the serum.
[0072] 13 - 3.無血清培養(細胞初代培養時) [0072] 13-3. Serum-free culture (at the time of primary cell culture)
初代培養を無血清培養で実施可能か否かについて検討した。 2- 3.及び 3— 3. においてそれぞれ、細胞単離後直ちに HSM培地(2 _ 3.の場合)及びエピラィフ(3 - 3.の場合)に縣濁する条件として培養を行い、培養開始 1週間後ディッシュを観察 し、接着細胞が存在するかを観察したが、いずれの場合もディッシュへの細胞の接着 が認められなかった。次に、 IPE培養液又は RPE培養液を用いる通常の方法(2— 3. 又は 3— 3. )にて 1週間培養を行った後に培地を HSM培地又はェピライフに変更を 行う条件で培養し、コンフルェントになるか否かを観察した。その結果、 IPE細胞及び RPE細胞のいずれについても良好な細胞増殖が認められ、 IPE細胞の場合は約 3週 後に、 RPE細胞の場合は約 4週後にコンフルェントに達した。以上の結果より、 IPE細 胞及び RPE細胞のいずれについても、初代培養の方法として無血清培養法を採用し 得ることが明らかとなった。 We examined whether primary culture could be performed in serum-free culture. 2- 3. and 3— 3. In each case, immediately after cell isolation, incubate under conditions that suspend in HSM medium (2-3) and epilarif (3-3), observe the dish one week after the start of culture, and observe adherent cells. In either case, cell adhesion to the dish was not observed. Next, after culturing for 1 week by the usual method (2-3 or 3-3) using IPE culture medium or RPE culture medium, the culture medium is cultured under the conditions for changing to HSM medium or Epilife. We observed whether it would become confluent. As a result, good cell proliferation was observed for both IPE cells and RPE cells, reaching confluence after about 3 weeks for IPE cells and about 4 weeks for RPE cells. From the above results, it was revealed that the serum-free culture method can be adopted as the primary culture method for both IPE cells and RPE cells.
13 -4.基質の種類、厚さ 13 -4. Substrate type and thickness
基質の種類と厚さについて検討した。まず、 2— 6.及び 3— 6. においてそれぞれ、 基質 (コラーゲンゲル薄膜)の成分であるコラーゲンの由来をブタとした条件で培養 細胞シートを作製し、細胞層の形態を観察した。具体的には細胞層を構成する細胞 が蜂の巣状の形状となるか否力を観察した。結果、ブタ由来のコラーゲンからなる基 質を使用しても、ゥシ由来のコラーゲン力もなる基質を使用した場合と同等の細胞層 を備える培養シートが得られることが判った。つまり、ゥシ由来に限らず、他の動物種 由来のコラーゲンを原料として調製した基質であっても、培養細胞シートの作製に有 用であることが明らかとなった。 The type and thickness of the substrate were examined. First, in 2-6 and 3-6, a cultured cell sheet was prepared under the condition that the origin of collagen as a component of the substrate (collagen gel thin film) was swine, and the morphology of the cell layer was observed. Specifically, it was observed whether the cells constituting the cell layer had a honeycomb shape. As a result, it was found that even when a substrate made of porcine collagen was used, a culture sheet having a cell layer equivalent to that obtained when a substrate having collagen power derived from ushi was used. In other words, it was clarified that even a substrate prepared using collagen derived from other animal species as a raw material, not only from ushi, is useful for producing cultured cell sheets.
次に、基質の厚さを 20 μ mから 10 a mに変更して培養細胞シートの作製を試みた。 尚、ゥシコラーゲンからなる基質とブタコラーゲンからなる基質の両者について検討し た。結果、コラーゲンの由来に拘わらず、基質の厚さが 10 μ πιになったとしても、厚さ 2 Ο μ πιの場合と同等の培養細胞シートを作製することができた。また、得られた培養細 胞シートは移植材料に要求される十分な強度及び形態保持性を備えていた。 Next, the thickness of the substrate was changed from 20 μm to 10 am, and an attempt was made to produce a cultured cell sheet. In addition, both a substrate made of ushi collagen and a substrate made of porcine collagen were examined. As a result, regardless of the origin of collagen, even when the thickness of the substrate was 10 μπι, a cultured cell sheet equivalent to the thickness of 2 μμπι could be produced. Moreover, the obtained cultured cell sheet had sufficient strength and form retention required for the transplant material.
培養細胞シートが移植される黄斑部網膜下は物理的なスペースに乏しぐ培養細 胞シートの厚みは全体で 20 z m以下であることが望ましい。以上の検討によって、 10 μ m厚の基質の使用が可能であることが明らかとなるとともに、実際に 20 μ m以下の 厚さの培養細胞シートの構築に成功した。 産業上の利用可能性 It is desirable that the thickness of the cultured cell sheet, which has less physical space under the macular part retina to which the cultured cell sheet is transplanted, is 20 zm or less in total. From the above study, it became clear that a 10 μm-thick substrate could be used, and in fact, a cultured cell sheet with a thickness of 20 μm or less was successfully constructed. Industrial applicability
[0074] 本発明の培養細胞シートは、網膜色素上皮(RPE)の移植が必要とされる各種疾患 における移植材料として用いることができる。本発明の培養細胞シートは、生体の RP Eに近似した構造の細胞層を備える。 [0074] The cultured cell sheet of the present invention can be used as a transplant material for various diseases that require transplantation of retinal pigment epithelium (RPE). The cultured cell sheet of the present invention includes a cell layer having a structure similar to that of living body RPE.
一方、本発明の培養細胞シートは、採取した IPE細胞又は RPE細胞を in vitroで培 養、増殖させることによって形成される。したがって、僅かな IPE細胞又は RPE細胞を もとに移植材料を作製することが可能であり、これらの細胞の数が減少した患者にお レ、ても自己の細胞を用いて移植材料を作製できる。このことは拒絶反応を生じない網 膜移植術を実現できることを意味する。 On the other hand, the cultured cell sheet of the present invention is formed by culturing and proliferating collected IPE cells or RPE cells in vitro. Therefore, it is possible to produce transplant material based on a small number of IPE cells or RPE cells, and even patients with a reduced number of these cells can make transplant material using their own cells. . This means that a network transplantation that does not cause rejection can be realized.
[0075] 現在、様々な組織を対象として、 ES細胞に代表される未分化細胞を利用した組織 の再建が試みられている。し力しながら、可能であれが自己細胞を利用することが望 まれる現状においては、 ES細胞等の利用は現実的ではな また克服すべき点も多 レ、。本発明の培養細胞シートは自己細胞を用いて構築することができる。 自己細胞 を用いれば、高い生着性を発揮し、治療効果に優れた細胞シートを構築することが 可能といえる。 [0075] Currently, reconstruction of tissues using undifferentiated cells typified by ES cells has been attempted for various tissues. However, in the current situation where it is desired to use autologous cells where possible, the use of ES cells is not realistic and there are many points to be overcome. The cultured cell sheet of the present invention can be constructed using autologous cells. If autologous cells are used, it can be said that a cell sheet that exhibits high engraftment and has an excellent therapeutic effect can be constructed.
[0076] この発明は、上記発明の実施の形態及び実施例の説明に何ら限定されるものでは ない。特許請求の範囲の記載を逸脱せず、当業者が容易に想到できる範囲で種々 の変形態様もこの発明に含まれる。 The present invention is not limited to the description of the embodiments and examples of the invention described above. Various modifications are also included in the present invention as long as those skilled in the art can easily conceive without departing from the scope of the claims.
本明細書の中で明示した論文、公開特許公報、及び特許公報などの内容は、その 全ての内容を援用によって引用することとする。 The contents of papers, published patent gazettes, patent gazettes, etc. specified in this specification are incorporated by reference in their entirety.
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005-265746 | 2005-09-13 | ||
| JP2005265746 | 2005-09-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2007032224A1 true WO2007032224A1 (en) | 2007-03-22 |
Family
ID=37864823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2006/317512 Ceased WO2007032224A1 (en) | 2005-09-13 | 2006-09-05 | Cultured cell sheet and method for preparation thereof |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2007032224A1 (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009084507A1 (en) * | 2007-12-28 | 2009-07-09 | Osaka University | Method of preparing layered collagen gel and layered collagen gel |
| JP2010046058A (en) * | 2008-07-24 | 2010-03-04 | Two Cells Co Ltd | Method for producing cultured cell for therapy |
| WO2012026531A1 (en) * | 2010-08-25 | 2012-03-01 | 独立行政法人農業生物資源研究所 | Dried hydrogel, dried vitrigel film, and processes for producing these |
| WO2012063925A1 (en) * | 2010-11-12 | 2012-05-18 | 独立行政法人農業生物資源研究所 | Cell culture chamber, method for producing same, tissue model using cell culture chamber, and method for producing same |
| WO2014208778A1 (en) * | 2013-06-28 | 2014-12-31 | 国立大学法人東北大学 | Cell-carrying patterned nano-thin film |
| EP3015091A4 (en) * | 2013-06-28 | 2017-03-29 | Saga University | Patch-type artificial skin preparation |
| JP2021510810A (en) * | 2018-01-11 | 2021-04-30 | センター フォー アイ リサーチ オーストラリア リミテッドCentre For Eye Research Australia Limited | Methods and systems for quantifying tissue biomarkers |
| WO2023210609A1 (en) * | 2022-04-27 | 2023-11-02 | ファーマバイオ株式会社 | Method for producing cell sheet |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09501303A (en) * | 1993-04-30 | 1997-02-10 | フォトジェネシス インコーポレイテッド | Retinal pigment epithelium transplant |
| WO2004033635A2 (en) * | 2002-10-04 | 2004-04-22 | Tissuetech, Inc. | Retinal pigment epithelial cell cultures on amniotic membrane and transplantation |
| JP2005503133A (en) * | 2001-06-01 | 2005-02-03 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | Microfabricated tissue as a substrate for pigment epithelium transplantation |
| WO2005014774A1 (en) * | 2003-08-11 | 2005-02-17 | National Institute Of Agrobiological Sciences | Carrier for culturing animal cell, and method for culturing or transplanting animal cell using said carrier for culture |
-
2006
- 2006-09-05 WO PCT/JP2006/317512 patent/WO2007032224A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09501303A (en) * | 1993-04-30 | 1997-02-10 | フォトジェネシス インコーポレイテッド | Retinal pigment epithelium transplant |
| JP2005503133A (en) * | 2001-06-01 | 2005-02-03 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | Microfabricated tissue as a substrate for pigment epithelium transplantation |
| WO2004033635A2 (en) * | 2002-10-04 | 2004-04-22 | Tissuetech, Inc. | Retinal pigment epithelial cell cultures on amniotic membrane and transplantation |
| WO2005014774A1 (en) * | 2003-08-11 | 2005-02-17 | National Institute Of Agrobiological Sciences | Carrier for culturing animal cell, and method for culturing or transplanting animal cell using said carrier for culture |
Non-Patent Citations (3)
| Title |
|---|
| BHATT N.S. ET AL.: "Experimental transplantation of human retinal pigment epithelial cells on collagen substrates", AMERICAN JOURNAL OF OPHTHALMOLOGY, vol. 117, no. 2, 1994, pages 214 - 221, XP003003825 * |
| TAKEZAWA T. ET AL.: "Collagen vitrigel: a novel scaffold that can facilitate a three-dimensional culture for reconstructing organoids", CELL TRANSPLANTATION, vol. 13, no. 4, 2004, pages 463 - 473, XP003003826 * |
| WANG P.C. ET AL.: "Reconstruction of renal glomerular tissue using collagen vitrigel scaffold", JOURNAL OF BIOSCIENCE AND BIOENGINEERING, vol. 99, no. 6, 2005, pages 529 - 540, XP004997047 * |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009084507A1 (en) * | 2007-12-28 | 2009-07-09 | Osaka University | Method of preparing layered collagen gel and layered collagen gel |
| JP2010046058A (en) * | 2008-07-24 | 2010-03-04 | Two Cells Co Ltd | Method for producing cultured cell for therapy |
| WO2012026531A1 (en) * | 2010-08-25 | 2012-03-01 | 独立行政法人農業生物資源研究所 | Dried hydrogel, dried vitrigel film, and processes for producing these |
| WO2012063925A1 (en) * | 2010-11-12 | 2012-05-18 | 独立行政法人農業生物資源研究所 | Cell culture chamber, method for producing same, tissue model using cell culture chamber, and method for producing same |
| WO2014208778A1 (en) * | 2013-06-28 | 2014-12-31 | 国立大学法人東北大学 | Cell-carrying patterned nano-thin film |
| EP3015091A4 (en) * | 2013-06-28 | 2017-03-29 | Saga University | Patch-type artificial skin preparation |
| JP2021510810A (en) * | 2018-01-11 | 2021-04-30 | センター フォー アイ リサーチ オーストラリア リミテッドCentre For Eye Research Australia Limited | Methods and systems for quantifying tissue biomarkers |
| JP7251873B2 (en) | 2018-01-11 | 2023-04-04 | センター フォー アイ リサーチ オーストラリア リミテッド | Methods and systems for quantifying tissue biomarkers |
| US11963721B2 (en) | 2018-01-11 | 2024-04-23 | Centre For Eye Research Australia Limited | Method and system for quantifying biomarker of a tissue |
| WO2023210609A1 (en) * | 2022-04-27 | 2023-11-02 | ファーマバイオ株式会社 | Method for producing cell sheet |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| da Cruz et al. | RPE transplantation and its role in retinal disease | |
| JP5946046B2 (en) | Human corneal endothelial cell sheet | |
| US7824671B2 (en) | Retinal pigment epithelial cell cultures on amniotic membrane and transplantation | |
| AU2004282525B2 (en) | Human corneal endothelial cells and methods of obtaining and culturing cells for corneal cell transplantation | |
| JP5255846B2 (en) | Corneal endothelial preparation capable of cell proliferation in vivo | |
| JP3490447B2 (en) | Retinal pigment epithelium transplantation | |
| Nicolini et al. | The anterior lens capsule used as support material in RPE cell‐transplantation | |
| Hartmann et al. | Human and porcine anterior lens capsule as support for growing and grafting retinal pigment epithelium and iris pigment epithelium | |
| Insler et al. | Heterologous transplantation versus enhancement of human corneal endothelium | |
| JP2004024852A (en) | Cornea endothelium-like sheet and manufacturing method therefor | |
| WO2007032224A1 (en) | Cultured cell sheet and method for preparation thereof | |
| WO2007043255A1 (en) | Cultured corneal endothelial sheet and method of producing the same | |
| WO2019189353A1 (en) | Sheet-like cell culture having penetrating structure | |
| US20090047738A1 (en) | Feeder cell derived from tissue stem cell | |
| Ho et al. | En bloc transfer of extracellular matrix in vitro | |
| Qu et al. | Reconstruction of corneal epithelium with cryopreserved corneal limbal stem cells in a rabbit model | |
| CN119799635A (en) | A method for culturing porcine limbal epithelial stem cells and its application | |
| JP7682398B2 (en) | Using retinal pigment epithelial cells to replace the corneal endothelium | |
| JP2009225675A (en) | Feeder cell derived from same kind of skin for preparing epithelial cell sheet | |
| RU2609253C1 (en) | Method for treating deep defects of cornea | |
| CN112569227B (en) | 3D (three-dimensional) transplantation material system with nerve protection function and application thereof | |
| JP7544807B2 (en) | Method for preparing allograft or xenograft material from a lens capsule - Patents.com | |
| WO2007130191A2 (en) | Isolaton and therapeutic application of adult retinal stem cells collected from extra-retinal tissues | |
| McCulley et al. | In vitro transfer of rabbit corneal epithelium from carriers to denuded corneas or cryolathed lenticules | |
| US20250318518A1 (en) | Cell-seeded substrates and related materials and methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 06797418 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: JP |